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Severe acute respiratory syndrome (SARS) is a recently described disease that 
has affected approximately 8,500 people worldwide with a mortality rate of 
approximately 10%. Although much effort has been spent in identifying and 
sequencing to better understand the virus SARS-CoV, only two vaccines have been 
developed and are currently used in clinical trials in China. Preliminary sequencing 
demonstrated that the CoV contains nine open reading frames (ORFs) which are 
significantly different from other coronavirus and was novel. This agent caused a 
more devastating clinical effect and fatality within two weeks in severely infected 
patients which contrasts the two known human coronaviruses (HCoV-299E and 
(HCoV-OC43), The lack of a cure for SARS-CoV infections necessitates the in depth 
and collaborative approach for the identification of suitable sites for the development 
of a vaccine or cure against SARS-CoV infections. 
The interactions between host and virus involves an important and intricate 
interplay between molecular pathways initiated by the host in response to the viral 
infection and the mechanisms triggered by the virus to successfully infect the cell. 
Often, this is the most important event in viral pathogenesis and is a frequent target 
for antiviral strategies. Understanding the transcriptomics involved during the 
interaction between the host and virus may provide clues to disease manifestations 
caused by the virus and provide the understanding of the infection for future 
undertakings to curb the disease. 
In order to identify potential interacting partners of the novel putative protein 
SARS 3A the gene encoding the 3A protein was first amplified from the isolated 
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genome RNA of SARS-CoV (2003VA2774 ) and cloned into a yeast-mammalian 
vector for mating using the Yeast Two Hybrid System (Y2H). 
This index case of SARS in Singapore occurred in a 23 year old Chinese 
woman who stayed on the 9th floor of a hotel during a vacation in Hong Kong and was 
believed to be exposed to the infection by a Chinese physician who stayed at same 
hotel during the same period. It was believed that this physician was also responsible 
for the various index cases in Vietnam and Canada. (Li et al., 2003) 
Cloning primers with restriction enzyme recognition sites were introduced to 
flank the gene specifically and constructed on a shuttle vector backbone. Although we 
were successful in cloning and expressing the 3A protein in our yeast bait, we were 
unable to obtain a working yeast mating partner from BD BioSciences and were 
hence unable to proceed with further mating experiments. Recently, studies have 
shown that 3A is a minor structural protein that does not cause apoptosis and is 
associated with numerous viral proteins eg, Nucleus, Membrane, Envelope, and Spike 
proteins. 
During SARS-CoV infection, the Spike protein is the first protein to interact 
with the host membrane and hence plays a crucial role in viral pathogenesis. The 
various transcriptomic changes that occurs within the cell following this interaction 
will provide for a clearer understanding of the role the Spike protein plays during 
SARS-CoV infection and more importantly, the downstream cellular genetic changes 
that will occur in the host cell.   
In order to gain insights into the cellular response to SARS-CoV Spike 
transfection, a human monocytic T cell derived cell line, HLCZ was employed as the 
host to probe into the transcriptional changes and events that occur in vitro. A 
previous study from our lab as well as other groups have already demonstrated live 
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infection of the whole SARS-CoV in Vero E6 cells showing that this particular cell 
line is highly susceptible to the newly emerging SARS-CoV infection. The studies 
have also shown various interesting genetic expression and changes that occur in Vero 
E6 cells.  
This served as the objective of our study using transfection only with a codon 
optimized cloned Spike protein construct, to determine which changes in gene 
expression in the host cell are attributed to the effect of Spike protein transfection. 
Furthermore, only a few studies have demonstrated SARS-CoV in human cell lines, 
even less so for specific cell lines involved in the immunological response eg. 
macrophages. Hence, SARS-CoV infection of human cell lines have not been fully 
established. Using the transfection model, we employed cDNA microarray analysis to 
study its effect on the cells and the changes in levels in expression of various genes. 
The codon optimized Spike construct showed a stronger expression after transfection 
in HLCZ cells and demonstrates heavy glycosylation of the Spike protein.  
Using Aquity analysis software and LOWESS normalization, a total of 102 
genes were found to display changes in levels of expression. Statistical analyses and 
real-time RT_PCR were performed to authenticate the microarray data. 61 genes were 
upregulated while 41 genes were downregulated upon transfection with SARS-CoV 
Spike expression construct. 3 major classes of genes that demonstrated changes in 
gene expression levels were those that encode: cell regulation proteins; proteins that 
are involved in trafficking, mainly ion channel proteins; transcriptional factors mainly 
zinc finger proteins. Various receptors and signal transduction genes were also found 
to demonstrate changes in gene expression levels.  
13 
Recently, CD209L (L-SIGN) has been identified as the receptor for SARS-
CoV and the protein Angiotensin Converting Enzyme 2 (ACE2) was identified as the 
main receptor for SARS-CoV Spike protein (Li et al; 2003, Prabakaran et al, 2004). 
Collectively, together with the microarray data, our analyses suggests the 
transcriptomic changes that would occur in a human cell upon infection by Spike 
protein and help to elucidate the numerous and complex cellular response that 

































In 2003, a novel strain of coronavirus caused severe outbreaks of atypical 
pneumonia in many parts of the world especially in South East Asia and China. 
Analysis of the complete nucleotide sequences of the SARS associated coronavirus 
(SARS-CoV) has shown its similarity to other known coronavirus (Rota et al., 2003; 
Marra et al., 2003; Zeng et al., 2004). The high mortality arising from the widespread 
virulence of SARS has triggered a heightened state of scientific interest to understand 
the mechanisms of pathogenicity of this virus (Lal et al., 2004) Although analysis of 
the complete nucleotide sequence of the SARS associated coronavirus (SARS-CoV) 
has shown significant similarities to the other coronavirus strains, identification of 
proteins had been rather difficult (Zeng et al., 2004). Currently, only the spike (S) 
glycoprotein, envelope (E) protein, membrane (M) glycoprotein and nucleocapsid (N) 
protein of this new strain of coronavirus have been identified to contain the same 
frame of sequence structure as other CoVs (Chia et al., 2004). In this new coronavirus 
strain, there exist 14 putative open reading frames (ORFs) which have not yet been 











1.1.1 Coronaviridae Classification 
The family of Coronaviridae of the order Nirovirales consist of 2 genus: 
Coronavirus and Torovirus. There are 3 main group species of virus in Coronavirus.  
GROUPING  NAME OF VIRUS VIRUS 
CODES 
GROUP 1 species Canine coronavirus  CCV 
 Feline coronavirus  FIPV 
 Feline infectious peritonitis virus FIPV 
 Human coronavirus 229E  HCoV-229E 
 Porcine epidemic diarrhea virus  (PEDV 
 Transmissible gastroenteritis virus  TGEV 
 Porcine respiratory virus  (PRCoV 
   
Group 2 species Bovine coronavirus  BCoV 
 Human coronavirus OC43  HCoV-OC43
 Murine hepatitis virus  MHV 
 Porcine hemagglutinating encephalomyelitis 
virus  
HEV 
 Rat coronavirus  RCV 
  Sialodacryoadenitis virus SDAV 
   
Group 3 species Infectious bronchitis virus  IBV 
 Turkey coronavirus  TCoV 
   
Ungrouped species Severe acute respiratory syndrom coronavirus SARS-CoV 
   
Unassigned species Rabbit coronavirus  RbCoV 
Table 1.  List of members of coronavirus separated into groups by 
molecular phylogenetics analyses of serological relatedness. 
 
 Most coronaviruses are transmitted by respiratory droplets or direct contact 
with infected patients and possibly by fomites. (CDC report 2003; Tsang et al., 2003)  
 
“Super Spreading Events” 
In certain circumstances, transmission of SARS-CoV was particularly efficient 
and resulted in individual patients infecting large numbers of people, referred to as 
“super-spreading events” (SSE), whereas in other situations, no secondary 
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transmission was observed . The mechanism of such high frequency transmission 
remains largely unknown. It was postulated that late admission to a hospital of more 
than 4 days after symptom onset could be partly responsible for the occurrence of 
SSEs (Li et al., 2004). 71.1% and 74.8% of all SARS infection in Hong Kong and 
Singapore were attributable to SSEs respectively. The reported SSEs in occurred in 
hospitals and each SSE case in Hong Kong caused more infections than in Singapore 
(Li et al., 2004) 
By using various statistical and mathematical analysis of the incubation period 
and time from onset of symptoms to hospital admissions as well as data from daily 
number of hospital admissions, Li et al were able to propose a model which estimates 
the daily number of newly infected cases which were usually not known during an 
epidemic, suggesting that control of the SARS epidemic would be directly governed 
by the ability to prevent/control the SSEs. 
 
1.1.2 Structure of Coronavirus 
Members of the family are characterized by having nuclear material that is 
positive-sense single stranded RNA. They are about 100nm in diameter and are the 
largest positive strand RNA viruses. The coronaviruses, along with the toroviruses 
and arteriviruses, belong to a group, the nidovirales, which produce a nested set of 
mRNA with a common 3’ end. The coronaviruses and the toroviruses (which together 
make up the Coronaviridae) have helical nucleocapsids while the arteriviruses have 
icosahedral nucleocapsids. Coronaviruses have an envelope that is derived from 
intracellular membranes and not the plasma membrane. In electron micrographs they 
have spikes sticking out of their surfaces (due to a large glycoprotein), leading to their 
name (corona = crown) (Stadler et al., 2003) 
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 Coronaviruses are believed to cause a large percentage of all common colds 
in adults primarily in the winter and early spring. They infect humans and animals in 
which they cause respiratory and enteric disease. Of the more than 30 isolated strains, 
three or four infect humans. The importance of coronaviruses as causative agents is 
hard to assess because, unlike rhinoviruses, they are difficult to grow in the 
laboratory. Coronavirus can also cause gastroenteritis. 
Typically, members of the family contain 5 proteins (S [spike], HE 
[hemagglutinin-esterase], M [membrane], E [envelope] and N [nucleocapsid]). 
 
1.1.3 Functions of proteins encoded by the Coronavirus genome 
Spike protein (S) 
This is a transmembrane glycoprotein of ~150kDa with three domains: the large 
extracellular domain (with two sub domains), the transmembrane sequence and the 
small cytosolic domain. The external domain (N-terminal) folds to a globular shape 
and forms the spike structures in electron micrographs. This region gives the virus its 
antigenic properties and contains the binding site for the cell surface receptor. The 
inner part of the external domain is probably coiled-coil and contains heptad repeats. 
There is a fatty acyl molecule here which may stabilize the protein in the lipid bilayer. 
The inner part of the external domain forms a stalk-like structure that associates with 
other S proteins to form a trimer. 
In some coronaviruses, the external domain is cleaved but the two parts of the 
glycoprotein remain associated by ionic interactions (in a similar manner to the gp120 
and gp41 of HIV). The inner part of the S protein, which may become exposed on 
binding to the host cell, is responsible for membrane fusion. Interestingly, the S 
protein has a region that is similar to the Fc-gamma receptors for immunoglobulins 
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allowing the virus to coat itself with these proteins and protect itself from immune 
attack (herpes viruses have a similar strategy). S protein can bind to sialic acid (9-O-
acetyl neuraminic acid) on the host cell surface, which gives the virus a 
hemagglutinating ability. Antibodies against S protein are neutralizing.  
 
HE protein (HE) 
Only some coronaviruses have a hemagglutinin esterase protein of ~65kDa 
and exists as a dimer. This structural protein makes short spikes at the surface of the 
virus and contains receptor binding and receptor-destroying activities HE protein 
mediates de-O-acetylation of N-acetyl-9-O-acetylneuraminic acid, which is probably 
the receptor determinant recognized by the virus on the surface of erythrocytes and 
susceptible cells. It can bind to sialic acid as well as and is able to cleave the sialic 
acid from a sugar chain by the esterase activity. This receptor-destroying activity is 
important for virus release as it probably helps preventing self-aggregation and 
ensures the efficient spread of the progeny virus from cell to cell.  
HE protein may serve as a secondary viral attachment protein for initiating 
infection, the spike protein being the major one. However, the HE protein is not 
absolute necessity for virus infection in culture. However, its presence in the virus 
may alter its pathogenicity. When the HE protein combines with the Spike protein of 
the JHM strain of Murine Hepatitis Virus (HEV), there was significant increased in 
viral spread and neurovirulence within the central nervous system, irregardless of the 
presence of whether the HE retained esterase activity (Kazi et al., 2005).  
Viral HE proteins may become a target for both the humoral and the cellular 
branches of the immune system. SARS CoV seems to lack the HE gene. 
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Membrane protein (M) 
This protein is a membrane spanning glycoprotein that helps in the attachment of 
nucelcapsid to the membranes of internal structures such as the Golgi bodies. Most of 
the protein is internal except only a small external N-terminal domain. During a viral 
infection, eg influenza infection, the N-terminal domain of the hemagglutinin (HA) 
inserts into the lipid membrane of red blood cells. It induces a pH change that causes 
a sharp folding and repositioning of Glu15 and Asp19 charged residues in the N-
terminal domain. This creates a hydrophobic pocket in the membrane, disrupting the 
structural integrity of lipid bilayer, thus causing hemolysis of red blood cell.  (Xing et. 
al., 2001) 
 
Envelope protein (E) 
This is a small protein on the viral membrane which is 9-12kD and can be 
located around the nucleus and and at the cell surface in infected cells. In HIV 
infection, the envelope protein resides on the surface of the virus. One part of the 
protein, gp120, allows the virus to bind to human cells while another subunit gp41 
mediates the fusion of the viral membrane and the cell membrane, thereby allowing 
the entry of the virus into the cell. (Chan et. al., 2997).  
 
Nucleocapsid protein (N) 
The nucleocapsid protein binds to the genomic RNA via the leader sequence 
and is ~60kDa. It also binds to the M protein on the inner surface of the viral 
membrane. N protein is phosphorylated. Unlike many other RNA viruses, coronavirus 
do not incorporate the RNA polymerase into the virus particle; rather the polymerase 
is made after infection by using the positive sense genomic RNA as an mRNA. This is 
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possible because the pol gene is at the 5’ end of the genome.   This gene codes 
encodes the RNA polymerase, the replicase and is about 20kB long. Sequencing 
shows that this gene actually contains two protein-coding sequences that are in 
different reading frames and overlap one another. However, the two sequences give 
rise to one protein, called a polyprotein, by ribosomal slippage when the ribosome 
comes to the beginning of the second sequence. As the huge polyprotein is being 
made, it is cut by proteases that are parts of the nascent protein. One of the proteins 
that is liberated is the RNA polymerase.  In retroviruses, conversion of the genomic 
single-stranded RNA into a double-stranded proviral DNA by RT takes place in the 
nucleocapsid substructure and involves two DNA strand transfers to generate the long 
terminal repeats (LTR) required for IN-mediated integration of the proviral DNA into 
the cellular genome and its expression. Recent biochemical and genetic data on 
retroviral NC proteins have shown that this small viral protein endowed with a strong 
affinity for nucleic acids exhibits nucleic acid annealing and strand transfer activities 
and is required for the formation of infectious viral particles. These new activities of 
NC protein are most probably necessary at the early steps of proviral DNA synthesis 
(Darlix et al., 1995)  
 
1.1.4 Clinical symptoms of Coronavirus infections 
Human coronaviruses are responsible for 10 - 30% of all common colds. All 
age groups are affected, and infection rates have been shown to be uniform for all age 
groups. This is different from other respiratory viruses such as Respiratory Syncytial 
Virus (RSV), where there is a distinct decrease in infection rates with an increase in 
age. The incubation period is short, being 2 to 4 days. Infection may also be 
subclinical or very mild. There have been some reports of more severe lower 
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respiratory tract involvement in young children and old people. Reinfection of 
individuals with the same human coronavirus serotype often occurs within 4 months 
of the first infection, suggesting that homologous antibodies are protective for only 4 
months. Although many people have high antibody levels after infection, reinfection 
with the same or related strains is common. Antibodies to one human coronavirus 
group may not be protective against infection with viruses from another group. 
 No antiviral drugs against coronaviruses are available and little research is 
being taken to produce any. However, vaccines against certain animal coronaviruses 
are available.  
 
1.1.5 History and epidemiology of SARS Co-V 
SARS first appeared in the Guangdong province of Southern china in 
November 2002 with an index case of a chef working in an exotic game restaurant. 
Subsequently similar cases were reported with family members and health workers in 
contact with this case. Many of the early patients have had epidemiological links to 
live animal market trade (Poon et al., 2004). Clinical symptoms include high fevers 
exceeding 38oC, myalgia, dry non productive dyspnea, lymphopaenia and infiltrate on 
chest radiography with resulting pneumonia leading to acute breathing problems in 
38% of cases (Stadler et al., 2003). The disease continued its spread throughout 
Guangdong and caused major outbreaks that primarily affected healthcare workers. 
With 305 cases from Guangdong province and 5 deaths, concern and panic among 
residents amounted as cases of SARS-CoV infection increased, leading to a 
surveillance initiative by the Hong Kong health authorities in Feb 2003 (Stadler et. al, 
2003). Initial fears of an outbreak of avian influenza H5N1 prompted the WHO to 
declare a global pandemic and the immediate development of vaccine. 
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However, on February 28, 2003, an index case was admitted into Hanoi’s 
Vietnam-France Hospital for a suspected avian flu infection that would turn out to be 
severe acute respiratory syndrome (SARS) (Donnelly et al 2003). Despite the 
heightened and strengthened infection control procedures introduced by the late Dr. 
Carlo Urbani, 80 people including many of the healthcare workers and he were 
infected by the index case and subsequently died. This prompted the WHO to provide 
a preliminary case definition and the naming of this novel strain of pneumonic 
influenza, severe acute respiratory syndrome (SARS). WHO issued global alerts and 
travel advisory warnings against unnecessary travel to affected countries and regions 
(Poon et al., 2004). 
 
1.1.6 Cause of the disease 
The alarming spread of this novel disease prompted a WHO initiative to gather 
a virtual network of laboratories across the world to contain this disease, with 
identification of the causal agent as the top priority. (Poon et, al. 2004). Identification 
of the causal agent was confounded as SARS-CoV had pleomorphic morphology 
compatible with paramyxoviruses but was not consistently isolated from various 
clinical subjects. (Stadler et al., 2003) The collaborative investigations soon managed 
to isolate an unidentified strain of coronavirus from infected Vero E6 and FRhK-1 
cells that had been exposed to clinical specimens from patients. Confirmation of the 
identity of the novel strain of coronavirus was performed using indirect 
immunofluorescence assay, thin-section microscopy of virus-infected cells and 
negatively stained preparations of cell culture supernatants (Poon et al., 2004) 
Three independent laboratories within the WHO network managed to 
sequence the open reading frame (ORF) 1b region of the replicase gene of the novel 
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strain of coronavirus (Poon et al., 2004). When macaques were challenged with the 
virus, they developed symptoms similar to those observed in human cases of SARS. 
Together with the previous studies, the virus as then successfully re-isolated from the 
lesions and positive antibody response to the virus confirmed that the new strain of 
coronavirus was the aetiological agent for SARS-CoV (Poon et al., 2004; Stadler et 
al., 2003). Experiments with various animal models showed that the most clinically 
significant disease occurred in infected macaques and ferrets.  
In Southern China, particularly in Guangdong, palm civets and raccoon dogs 
were considered delicacies. This led to the hypothesis that the SARS-CoV had 
recently acquired the ability to “hop across species barrier through exposure whilst 
handling of live wild game for the restaurant trade for game meat. Sampling of the 
animals revealed that some of them carried a virus genetically and antigenically 
related to the human SARS coronavirus (Poon et al., 2004; Guan et al., 2003) 
Interestingly, animal coronavirus seem to cause a more severe outbreak of the disease 
as compared compared to other human coronavirus. Through aggressive quarantine 
measures and cooperation between the WHO network and the various countries, the 
SARS epidemic was finally brought under control after 100 days with 8,098 probable 
SARS cases and 774 deaths worldwide across 29 countries (Stadler et al., 2003) 
 
1.1.7 Clinical symptoms and pathology of SARS-CoV infection 
The incubation period for SARS is typically 2 to 7 days; however, isolated 
reports have suggested an incubation period as long as 10 days. The illness begins 
generally with a prodrome (an early symptom) of fever (>100.4°F [>38.0°C]). Fever 
often is high, sometimes is associated with chills and rigors, and might be 
accompanied by other symptoms, including headache, malaise, and myalgia. At the 
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onset of illness, some persons have mild respiratory symptoms. Typically, rash and 
neurologic or gastrointestinal findings are absent; however, some patients have 
reported diarrhea during the febrile prodrome.  
After 3 to 7 days, a lower respiratory phase begins with the onset of a dry, 
nonproductive cough or dyspnea, which might be accompanied by or progress to 
hypoxemia. In 10% to 20% of cases, the respiratory illness is severe enough to require 
intubation and mechanical ventilation. The case-fatality rate among persons with 
illness meeting the current WHO case definition of SARS is approximately 3%.  
Chest radiographs might be normal during the febrile prodrome and 
throughout the course of illness. However, in a substantial proportion of patients, the 
respiratory phase is characterized by early focal interstitial infiltrates progressing to 
more generalized, patchy, interstitial infiltrates. Some chest radiographs from patients 
in the late stages of SARS also have shown areas of consolidation.  
Early in the course of disease, the absolute lymphocyte count is often 
decreased. Overall white blood cell counts have generally been normal or decreased. 
At the peak of the respiratory illness, approximately 50% of patients have leukopenia 
and thrombocytopenia or low-normal platelet counts (50,000 to 150,000/µL). Early in 
the respiratory phase, elevated creatine phosphokinase levels (as high as 3,000 IU/L) 
and hepatic transaminases (two to six times the upper limits of normal) have been 
noted. In the majority of patients, renal function has remained normal.  
The severity of illness might be highly variable, ranging from mild illness to 
death. Although a few close contacts of patients with SARS have developed a similar 
illness, the majority has remained well. Some close contacts have reported a mild, 
febrile illness without respiratory signs or symptoms, suggesting the illness might not 
always progress to the respiratory phase. (Fleischaue et al., 2003) 
26 
Treatment regimens have included several antibiotics to presumptively treat 
known bacterial agents of atypical pneumonia. In several locations, therapy also has 
included antiviral agents such as oseltamivir or ribavirin. Steroids have also been 
administered orally or intravenously to patients in combination with ribavirin and 
other antimicrobials. At present, there is no cure for SARS-CoV infections. 
 
1.1.8 SARS CoV unique characteristics 
Members of the Coronaviridae are a group of enveloped positive-stranded 
RNA viruses with the largest genome among the RNA viruses (Zhu et al., 2004) and 
contain five major ORFs which encodes the replicase, spike (S), envelope (ENV), 
membrane (M) and nucleocapsid (N) proteins (Poon et al., 2004). The spherical 
nucleocapsid consists of a positive strand RNA genome of about 30kb and has club-
shaped peplomers that radiate outwards from the envelope, giving rise to solis like 





Figure 1. Electronmicrograph and schematic diagram of SARS coronavirus.  
Picture adapted from Stadler et al., 2003.  
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Coronaviruses are divided into three antigenically distinct groups: Group 1 
consists of all previously known human coronavirus. Group II consists of human 
coronavirus OC43 (HCoV-OC43), mouse hepatitis virus (MHV), bovine coronavirus 
(BCoV) and others while Group III consists of mainly avian coronavirus (Lai et al., 
2003).  
 
 SARS CoV genome is different from  other Coronavirus 
SARS-CoV has a genome of 29,727 bases and eleven open reading frames. 
The sequence, though similar to other coronaviruses, is sufficiently different to make 
this a member of a new coronavirus group. The organization of the genome is very 
similar to that of other coronaviruses (5’ replicase (rep), spike (S), envelope (E), 
membrane (M), nucleocapsid (N)-3' and short untranslated regions at both termini). 
The replicase gene occupies the 5’ two-thirds of the genome and has, like other 
coronaviruses, two overlapping open reading frames. It also codes for a protease in 
the pol polyprotein. Beside the S, M, E and N proteins, SARS-CoV contains several 
accessory genes that encode non-structural proteins that are dispensable for virus 
viability. (Stadler et al., 2003) There are nine possible open reading frames that are 
found in varying arrangements in other coronaviruses and may code for proteins that 
are unique to the SARS virus. Using antibody tests, SARS-coronavirus has been 
associated with SARS cases throughout the world. SARS-CoV showed some 
serological cross reactivity with antisera to some Group 1 viruses and does not 
contain a haemagluttinin-esterase protein found in Group II viruses. The viral 
sequence analysis showed low homology to all previously known coronaviruses, 
suggesting that it is a novel coronavirus (Poon et al., 2004). Genetic sequencing 
carried out in various studies to elucidate the origins of this coronavirus, suggest a 
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complex evolutionary history of recombination for SARS-CoV.  This was particularly 
highlighted in the RNA dependent RNA polymerase as well as in the nsp9 and nsp10 
regions and a segment of nsp14 of SARS CoV (Stanhope et al., 2003; Rest et al., 
2003). Using full viral genome sequence, even within SARS CoV strains,there were 
nucleotide differences in 34 locations and that there were no significant sequences 
matches to other ORF’s in the last one thirds of the viral genome. Exploratory 
phylogenetic analyses of the Spike, M and N genomic regions revealed that the 
SARS-CoV sequences were related more closely to Group II coronaviruses than the 
other groups. There was also evidence of similarity of the human SARS-CoV to 
Group III coronavirus, suggesting that SARS-CoV did recombine with a member of 
the group and that avian coronavirus was partly involved in the evolution of this novel 
virus. Other recombination events including Group I showed that SARS-CoV had a 
past history of recombination with coronaviruses hosted in distinct animal groups and 
the mixed animal husbandry practices in close proximity to human populations could 
have led to the evolution of the SARS coronavirus and facilitated its progression as an 
infectious disease in humans (Standhope et al., 2003) This was further supported by 
the observation of recent influenza viruses arising from the multi reassortment of 
avian, porcine and human influenza viruses. (Gregory et al., 2003; Zhou et al., 1999; 
Bush, 2004)  The genomic sequences of SARS-CoV from human and palm civets in 
Guangzhou were nearly identical, and phylogenetical analysis suggested an 
independent viral invasion from animal to human. Sequencing studies identified 202 
single nucleotide variations, among which, 17 are polymorphic in palm civets only. 
Furthermore, major genetic variations in the Spike gene particularly at the S1 subunit, 
seemed essential for the transition from animal-to-human transmission to human-to-
human transmission (Song et. al., 2004)  
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1.1.9 SARS CoV spike protein 
Enveloped viruses have membrane glycoproteins that mediate entry into host 
cells (Hoffmann et al., 2004). Based on sequence alignments and genetic information 
from other coronavirus, the spike glycoprotein is thought to be of particularly 
importance in the infectious process of SARS as it is the site for the virus to interact 
with a functional receptor and has a role in cell membrane recognition and fusion as 
well as it has the ability to evade the host’s immune defenses (Chang et al., 2004; Li 
et al., 2004) suggesting that S protein is the main virulence factor of coronavirus (Hua 
et al., 2004; Gallagher et al., 2001).  
 
Figure 2.  Schematic diagram of the Spike protein of SARS-CoV. 
Picture adapted from Song et al., 2003. 
 
During infection by SARS-CoV, the S-protein aids in the attachment to cells 
and promotes the fusion of viral and cellular membranes, allowing insertion of the 
viral genome into the cellular cytoplasm (Hofmann et al., 2004). The protein plays an 
important role in virus entry, virus-receptor interactions and virus tropism. Either 
class 1 or class II RNA viral fusion proteins mediate fusion. Sainz et al, 2004 reported 
that class 1 fusion proteins contains  
1.  A fusion peptide at or near the amino terminus consisting of a stretch 
of ~20 hydrophobic amino acids 
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2. a pair of extended α helices, specifically 4,5-hydrophobic heptad 
repeats (HR) 
3. a cluster of aromatic amino acids proximal to  
4. a hydrophobic transmembrane anchoring domain. 
and that many viruses encode these class 1 fusion proteins. 
The S-protein of SARS CoV is a type 1 membrane glycoprotein consisting of 
1,255 amino acids and forms the spike structure that is commonly found on other 
coronoaviruses. It consists of a leader of 14 a.a, an ectodomain of 1,175 a.a., a 
membrane spanning region of 36 a.a, and a shorter intracellular tail of 28 a.a. 
(Babcock et al., 2004) which may be cleaved by virus-encoded or host-encoded 
proteinases into 2 functional subunits, S1 and S2 (Yu et al., 2005; John et al., 2000). 
Using a pH dependent mechanism, SARS CoV S is able to mediate viral entry into 
dendritic cells (DC), similar to that of Ebola virus and vesicular stomatitis virus, and 
is then transfered to susceptible target cells (eg, human respiratory tract cells, human 
renal epithelial cells, etc) through matured dentritic cells (mDC) (Yang et al., 2004).  
The S1 subunit of SARS Co-V is an external domain which consists of the 
receptor binding domain while S2 is a C-terminal membrane associated subunit, 
which mediates fusion between viral and target cell membranes. The S1 unit forms a 
surface knob like feature (Yu et al., 2005) that binds to receptors on the target cells. 
Studies by Li and colleagues demonstrated the presence of a metallopeptidase named 
angiotensin-converting enzyme 2 (ACE2) protein as the functional receptor for SARS 
and that ACE2 can be immunoprecipitated from Vero E6 cells by the S1 domain of 
the SARS-CoV S protein, that it mediates fusion with S-protein-expressing cells, and 
that it promotes viral replication in a cell line otherwise inefficient for SARS-CoV 
infection (Li et al., 2003) Although the function of ACE2 is thought to be an essential 
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regulator of cardiac function, its role has not been completely defined. The 
distribution of ACE2 in tissues thus would have a major impact to determine the 
possible binding sites of SARS CoV through its S protein. ACE2 was found in 
endothelial cells and smooth muscle cells, in myofibroblasts and the membrane of fat 
cells in various organs. Immunolocalization studies showed that alveolar epithelial 
cells as well as enterocytes of the small intestine were markedly positive for ACE2 
(Hamming et al., 2004). It is highly likely that alveolar pneumocytes in the lungs are 
the possible site of entrance for SARS-CoV. However, detailed cell type studies have 
demonstrated that only a few organs can become virus positive despite the abundance 
of ACE2 on endothelia of all organs. This suggests that SARS-CoV could require a co 
receptor for cellular entry (Hamming et al., 2004).  
ACE2 promotes viral replication in a cell line but does not bind to human 
kidney 293T cells. This was supported by the studies that showed inhibition of 
syncytia formation and viral replication by anti-ACE2 antibody (Li et, al., 2003). The 
exact site of binding of the S1 unit to ACE2 was deduced to be within residues 318-
510, which blocks S protein-mediated infection (Yu et, al., 2005) 
Another alternative marker was identified that can serve as an alternative 
receptor for SARS-CoV. Recently, Jeffers et al discovered an additional receptor for 
SARS-CoV, CD209L (also known as L-SIGN, DCSIGNR, and DC-SIGN2) and since 
CD209L is expressed in human type II alveolar cells and lung endothelial cells, it may 
be targets for SARS-CoV to utilize for infection. As SARS-CoV infection in humans 
primarily targets the lung and gastrointestinal tract, expression of CD209L in 
combination with ACE2 in lymph nodes, payer’s patches and lung may contribute to 
the spread of the virus (Jeffers et al., 2004). This marker has also been expressed on 
dendritic cells, monocytes, alveolar macrophages and placenta.   
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The S2 domain contains a putative fusion peptide and two heptad repeats 
(HR1 and HR2) regions that can associate to form a six-helix bundle structure. When 
S1 binds to ACE2 receptor on the cells, S2 changes its conformation by interaction 
between the HR1 and HR2 regions to form a fusogenic core which bring viral and 
target cell membrane into close proximity, resulting in fusion of the two surfaces and 
entry (Liu et al., 2004; He et al., 2004). One of the peptides (CP-1) found within the 
HR-2 region, was hypothesized to bind to the HR1 region that interfere with the 
conformational changes between HR1 and HR2, resulting in the inhibiting SARS-
CoV fusion with the target cell membrane (Liu et, al., 2004). Such findings suggest 
that enhancing the interaction of CP-1 and HR1 could be used as a target for the 
designs of specific antiviral agents for treatment.  
Although there are a number of SARS vaccine candidates, which includes 
inactivated SARS-CoV vaccines, DNA vaccines, and attenuated virus vaccines 
expressing SARS-CoV specific protein, only one is being tested in a clinical trial in 
China. (He et, al., 2004).  The receptor binding domain of the S1 subunit of the S 
proteins of SARS-CoV have been demonstrated to illicit significant levels of 
neutralizing antibodies and protective immunity against viral challenge in immunized 
animals. (He et, al., 2004; Bisht et, al., 2004, Yang et. al., 2004). 
 
1.2 SARS-CoV 3A putative protein 
The genome of SARS-CoV also consists of 14 putative open reading frames 
(ORFs) encoding 6 known and 8 unknown proteins (Yu et al., 2004; Snijder et al., 
2003; Thiel et al., 2003). Analysis of the genomic structure of SARS-CoV showed 
that a gene locus containing ORF3a and 3b located between the S and E genes exist in 
all the other coronavirus and is thought to be related to viral virulence and 
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pathogenesis (Zeng et al., 2004). This putative protein 3A is also known as protein X1 
(Rota et al., 2003). It is a membrane-associated protein that is distributed over the 
cytoplasm in a fine punctuate pattern with slight aggregation at the Golgi apparatus 
(Yu et al., 2004). Orf 3a encodes a putative 31kDA protein containing 274 amino acid 
residues. Using predictive protein software together with DNASTAR analysis, Zeng 
et al showed the existence of 3 transmembrane regions within the 3a protein. The N 
terminal region is on the outer surface of the viral particle and contains a putative 
signal peptide, a C terminal region located in the interior of the viral particle and a 
possible cytoplasmic region of Ca- ATPase. There exist a cystein-rich motif in protein 
3a that overlaps with the 3 membrane-spanning domain and the cytoplasmic tail of the 
protein. Within this motif, there exist 3 cystein residues whose presence in a single 
plane on the surface in protein 3a enables the formation of interchain disulfide 
linkages with other viral structural proteins. (Zeng et al., 2004). SARS 3A cds 
encodes a minor structural protein which is associated with the S protein on the 
surface of the SARS-CoV viral envelope and is evolved in synergy with the S protein. 
(Song et. al., 2004). Preliminary studies have shown that under both reducing and 
non-reducing conditions, 2 bands around 210kDa were obtained and when the 
antibodies were reversed, the same observation was seen, suggesting that protein 3a 
binds to the spike protein with the interchain disulfide bonds on the interior of the 
virus (Zeng et al., 2004) Although studies suggests the sequence of protein 3a has 
some homology with various organisms, the overall sequence of the protein still lacks 




 In pre-infected cells with SARS-CoV, protein 3a was detected only in lung 
sections and not the rest of the organs. Using confocal microscopy, Yu et al was able 
to demonstrate expression of 3a in Golgi apparatus but not within the endoplasmic 
reticulum, lysosome or mitochondria.  
Sequencing and phylogenetic studies have been demonstrated by Zeng et al 
that the 3a protein probably evolved from the SNE locus of porcine epidemic 
diarrhoea virus (PEDV) or a PEDV like ancestor, which exists widely in all the groups 
of the coronavirus family. 
 
1.2.1 Other SARSCoV putative proteins. 
Beside the spike protein and factor 3a, other ORFs play an important role in 
the mechanism of pathogenicity in SARS-CoV. The SARS-CoV nucleocapsid (N) 
protein is a predicted phosphor-protein of 46kDa, which has a short serine-rich stretch 
and a putative bipartite nuclear localization signal and is involved in capsid assembly 
and to activate Akaline Phosphatase 1 (AP1) signal transduction pathway. (Lal et al., 
2004; He et al., 2003) Under stressed conditions, COS-1 cells transfected with SARS-
CoV N showed significant apoptosis when cultured under serum starvation and could 
be due to the interference of the integrin signally pathway through the down 
regulation of fibronectin and levels of phosphorylated Focal Adhesion Kinase (FAK). 
(Lal et al., 2004) Mutational studies by Lal et al demonstrated that when N was 
constructed on a p110α backbone (mutant of PI3K), inhibition of caspase 3 activation 





1.2.2 ORF 7A 
Another putative protein 7a was recently found to induce apoptosis via a 
caspase dependent pathway (Tan et al., 2004). Overexpression of a HA-tagged 7a 
construct by Tan et al demonstrated the increase in caspase-3 protease activity that is 
a hallmark of apoptosis.    
Orf 7a contains a signal peptide at the N terminus, a transmembrane domain 
and a short cytoplasmic tail containing the endoplasmic reticulum (ER) retrieval motif 
KRKTE at the C terminus (Fielding et al., 2004). Immunofluorescence studies 
demonstrated that ORF 7a was detected in the perinuclear region and associated with 
ER. Further studies by Fielding et al revealed that mutation of the 2 key lysine amino 
acid residues in the protein motif (KRKTE) resulted in abolishment of the ER 
localization of the reporter proteins. This motif is a crucial arrangement as the motif 
either function as a retrieval or retention signal with signals important for the 
transport of the proteins back to the ER from the intermediate compartment (Fielding 
et al., 2004). Furthermore, ORF 7a was shown to be able to interact with ORF 3a, 
which, on the contrary, does not induce apoptosis.  
 
1.3 PROTEOMICS  
The term proteomics was first coined in 1995 to define the large-scale study of 
the entire protein complement of a cell line, tissue or organism. Although there has 
been large scale sequencing projects and genomics that generated vast amounts of 
information of genetic material, it is clear that the study of genes alone cannot yield 
answers to the many biological questions. Proteins are expressed by the cells largely 
determine its phenotype. Analysis of the mRNA transcripts cannot provide 
information on post-translational modification of proteins such as phosphorylation, 
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which is often determined by regulatory signals and interaction with other proteins 
and glycosylation (Steiner and Witzmann, 2000).  
Although attemps have been made to assign functions to newly characterized 
or predicted genes through database similarity searches and homology predictions, no 
function can yet be assigned for one-third of the sequences in organisms whose 
sequence has been obtained (Eisenstein et al., 2000). Thus proteomics really is the 
complement of the information derived from genomic studies. 
 
The study of proteomics can be broadly classified into 2 aspects:-  
Expression proteomics is the quantitative study of protein expression between 
samples that differ from each other by some parameter and the comparisons of such 
differences in protein expression under specific condition can be compared between 
different samples. Information derived from such a comparison can be used to deduce 
proteins involved in many of the cell signaling transduction or identification of 
disease-specific genes. Another useful application is the understanding of particular 
proteome responses to drug treatments or in toxicological studies. (Blackstock and 
Weir, 1999; Banks et al., 2000)   
The other aspect is the study of structural and interaction proteomics. Such 
studies aim to identify all the proteins within a complex to determine their cellular 
location and to characterize all protein-protein interactions (Anderson et al., 2000). 
Information obtained from such studies contributes to the understanding of the overall 
architecture of the cells and explains the expression of certain proteins giving the cell 
its unique characteristics. Protein-protein interaction studies can be harness to study 
the specific processes in signaling pathways, which can be consolidated in the 
establishment of protein interaction maps for various cells and conditions. 
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(Blackstock and Weir, 1999; Anderson et al., 2000). The functions can be assigned to 
proteins if they demonstrate the ability to interact with another protein of a known 
function.  
 
1.3.1 The Yeast Two Hybrid Principle 
This method was first developed by Fields and Song (1989) as an assay to 
detect protein-protein interactions in vivo. The principle relies on the modular nature 
of transcription factors, which can be divided into two functionally distinct domains 
that mediate DNA binding (BD) and transcriptional activation (AD) domains. In the 
classical Y2H, the “bait” is constructed by fusing a protein A to the BD derived from 
a transcriptional factor, eg GAL4 or LexA, while the “prey” is constructed by fusing 
another protein B to the AD, eg GAL4 or VP16 of another transcriptional factor. Co-
expression of protein interacting pairs in yeast will bring the AD and BD domains into 
close proximity to each other and activate the active transcriptional factor. This 
activator is then able to activate the transcriptional activation of reporter gene(s) 
which then gives a phenotypic readout. Commonly used reporter genes include 
auxotrophic markers eg, HIS3, LEU2 and ADE. Usually, a colorimetric report can be 
obtained when lacZ is used together with auxotrophic markers. 
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Fig3 The Yeast 2 Hybrid Principle (adapted from Chua et al, 2004 ) 
 
 
1.3.2 Variations of the Y2H  
Despite the success of using the yeast two hybrid protocol to detect more than 
50% of all interactions, the system has several limitations. Certain proteins such as 
transcriptional activators can autoactivate the reporter genes and gives rise to false 
positives. The original system required a transport system for the delivery of fusion 
proteins to the yeast nucleus to activate the expression of reporter genes. Certain 
integral transmembrane proteins the may be inappropriately folded during 
translocation to the nucleus were unsuitable to be tested with the original Y2H (Van 
Criekinge and Beyaert, 1999; Aronheim, 2001) 
 As such, there have been several variations of the Y2H system that include the 
SOS recruitment system [(SRS) (Aronhein et al., 1997)] and RNA polymerase III 
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based two-hybrid systems (Marsolier et al., 1997), which are suitable when 
transcriptional activators are to be tested. For large transmembrane proteins to be 
studies, the Ras recruitment system [(RRS) (Broder et al., 1998)] and the split-
ubiquitin system (Johnson and Varshavsky, 1994) are suitable. 
 Newer systems have been developed for the detection of protein interactions 
in mammalian systems. These have been designed to circumvent differences in post-
translational modifications between yeast and mammalian systems. These include the 
mammalian RRS system (Maroun and Aronheim, 1999) as well as the usage of green 
fluorescent protein (GFP) reporter (Shioda et al., 2000; Fotin-Mlexzek et al., 2000). 
 
1.4 OBJECTIVES 
The 3 objectives of this study are:- 
a. To isolate and construct clones expressing 3A protein in yeast and to 
attempt to identify interacting partners using the Yeast Two Hybrid 
System.  
 
b. To isolate and construct clones expressing Spike protein in Vero E6, HEK 
293T and HLCZ mammalian cell lines 
 
c. To analyse the cellular transcriptomics of Spike gene transfection of 
HLCZ cells and compare with the transcriptome of cell infected with live 

































2.0 EXPRESSION CLONING 
 
2.1  CDNA synthesis using Reverse Transcription 
 1-5µg of SARS total RNA from an infected index case was obtained and first 
mixed with 10mM of each dNTP, 10ng of random hexamers and ddH2O in a total 
volume of 12µl and incubated for 65oC for 3 minutes. The tube was then chilled on 
ice quickly. 4µl of first strand buffer, 2µl of 0.1M DTT and 1µl of 10mM each dNTPs 
were added to the tube, mixed and incubated at 42oC for 2 minutes. 200 units of 
SUPERSCRIPTTM (Invitrogen) was added to the reaction mixture and incubated at 
42oC for 90min after which the reactions was inactivated at 70oC for 15 minutes.2 
units of E. coli RNaseH was added to the reaction mixture and incubated at 37oC for 
20min. The synthesized cDNA were stored at -20oC until required. 
 
2.1.1 Oligonucleotide primers design 
 All the primers used in this study were custom synthesized by Research 
Biolabs or PrOligo. 
 
2.1.2 Vectors used in PCR and Cloning.  
Table 2.1 lists the vectors used in this project that were supplied by the 
manufacturers as well as the sequencing primers flanking the Multiple Cloning Site 






Vector Name Sequencing primers (5’- 3’) 
pGBKT7 
























(Clontech, Palto Alto, CA, USA) 
  
 Table 2. List of vectors and sequencing primers used for screening of vector 
constructs 
 
All the vectors were obtained from listed manufacturers except 
pcDNA3.1/Myc-His which was obtained as a plasmid of codon optimized SARS 
Spike protein constructed on a pcDNA3.1/Myc-His vector backbone. The supplied 
oligonucleotides were used to amplify or screen the inserts throughout the project.  
 
2.1.3 List of Oligonucleotides synthesized during the project 
The published sequences of SARS3A gene were obtained from GenBank for 
the design of 5 primers with various flanking Restriction Enzyme (R.E.) nucleotide 
sequences (Table 2). These flanking regions correspond to the corresponding RE cut 



















5’                   3’ 
SARS3AF1a 
(Forward) 





























Table 3 List of primers used for PCR and sequencing of insert during 
cloning. RE recognition sites are highlighted in blue 
 
Set A consist of primers SARS3AF1a which has a 5’ EcoR1 RE recognition 
site of G AATTC overhang and SARS3AR1 consisting of a 3’ Sma1 RE recognition 
site of CCC GGG overhang. PCR products generated from a combination of these 2 
primers were restricted into pGBKT7 vector in the respective MCS.  
Primers in set B were used in PCR and the amplification of PCR products 
flanked by SARS3AF1b consisting of a 5’ EcoR1 RE cut site and SARS2AR1b1 
consisting of a 3’ Sal1 RE recognition site of G TCGAC. PCR products generated 
from a combination of these 2 primers were restricted and cloned into pCMV-Myc in 
the respective MCS.  
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For the construction of the 3A-EGFP-fusion protein PCR products were 
amplified with SARS3AF1b and SARS3AR2b1. The insert contains EcoR1 RE and 
Sal1 RE overhangs.   
 
2.1.4 Polymerase chain reaction (PCR) 
The PCR reactions carried out in this study had a final reaction volume of 
50µl containing 1-2µl of DNA template, 5µl of 10X PCR buffer, 3µl of MgCl2, 1µl of 
10mM dNTPs (dATP, dCTP, dTTP, dGTP), 1µl of 10mM each of primers pairs 
(Table 1) and 0.5µl Taq DNA polymerase. The volume was topped to 50µl with 
sterile ddH2O. 
For the PCR reactions using primers in table 1, the reaction mixtures were 
subjected to a generic PCR cycle profile of denaturation at 95oC for 1 minute 
preceeding 30 cycles of denaturation at 95oC for 30 seconds, annealing at 60oC for 30 
seconds, and extension at 72oC. The PCR reactions were then stored at 4oC for further 
analysis using agarose gel electrophoresis. 
 
2.1.5 Agarose gel electrophoresis 
All the PCR reactions analysed were subjected to gel electrophoresis in a 1.6% 
1X TBE agarose gel prestained with ethidium bromide (EtBr). 10µl of PCR products 
were mixed with 1µl of 10X Gel loading buffer alongside 10µl of 1kb Plus DNA 
molecular weight ladder [0.1µg/µl (Invitrogen)]. The gel was subjected to 
electrophoresis at 175V for 2 hours and subsequently rinsed in ddH2O and visualized 
over an UV transilluminator.  
The gel images were captured using the KODAK electrophoresis 
Documentation and Analysis System (EDAS) 120 (Eastman Kodak, USA). 
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2.1.6 Extraction and purification of DNA from agarose gel. 
 After gel electrophoresis, DNA bands of the correct size based on the 
molecular weight marker were excised from the gel and purified using the Qiaquick 
gel extraction kit (Qiagen, Hilden, Germany) following the manufacturer’s protocols. 
The eluted DNA was then stored in -20oC until required. 
 
2.1.7 DNA Sequencing 
DNA sequencing was performed using the ABI PRISM BigDyeTM Terminator 
Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA USA). 
The composition of the sequencing reaction, the sequencing profiles and the 
purification of the extension products were performed as recommended by the 
manufacturer’s protocol. The precipitated extension products were then stored at -
20oC until they were sent for electrophoresis at the National University Medical 
Institute (NUMI, Singapore) sequencing laboratory. Both the sequencing 



















2.2 TA CLONING AND GENERATION OF GENETIC 
CONSTRUCTS CONTAINING THE 3A AND SPIKE 
PROTEIN OF SARS-COV 
 
2.2.1 TA cloning using TOPO XL 
PCR products were generated using 3 different primer sets (Table 1). The PCR 
band generated by primer set A consists of an EcoR1 and Sma1 restriction enzyme 
recognition site. The PCR products generated by primer set B and C both consist of an 
EcoR1 and Sal1 restriction enzyme recognition sites at the flanking ends.  
Taq polymerase has an intrinsic terminal transferase activity for adding A 
residues to the 3’ end of PCR products. Using T vectors, vectors with a single T 
overhang, the PCR products and T vectors were ligated with T4 DNA ligase. For this 
study, the TOPO XL PCR Cloning Kit (Invitrogen) was used according to the 
manufacturer’s protocol.    
PCR products generated by primer sets A, B and C were TA cloned into T 
vector and transformed into competent E. coli TOP 10 cells and plated onto LB agar 
plates containing kanamycin and incubated at 37oC overnight. 
Clones that survived the antibiotic selection were picked and subjected to 
colony PCR. Clones that gave a positive band for the inserts generated by the 3 primer 
sets were then inoculated into 50ml LB broth containing kanamycin and incubated at 
37oC with constant shaking 230 rpm in an incubator for 16 hours.  
The PCR band amplified by primer set A was ligated into vector pGBKT7-myc 
in a restriction reaction. The PCR band amplified by primer set B was ligated into 
vector pCMV-myc in a restriction reaction, while the band amplified by primer set C 
was ligated into vector pGFP in another restriction reaction. The ligation of various 
PCR bands and corresponding vectors followed the generic formulae:- 
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Vector DNA 100ng 
Insert DNA 50ng 
T4 DNA Ligase 1µl 
Ligase 10X Buffer 1µl 
Sterile ddH2O Top up to final volume 
Total volume 10µl 
 
 
The ligation reactions were incubated at 4oC for at least 16 hours. Thereafter, 2-3µl of 
the ligated mix were subjected to gel electrophoresis for further analysis.  
 
 
2.3 DNA CLONING 
 
2.3.1 Cloning using RE digested PCR fragments. 
Complete digestion of PCR products of 3A amplified by primer set A using 
EcoR1 and Sma1 enzymes (Promega) were carried out for 2 to 4 hours or overnight in 
a 37oC water bath with appropriate buffers as recommended by the manufacturer. 
Complete digestion of PCR products amplified by primer set B and C using Eco R1 
and Sal 1 enzymes (Promega) were carried out overnight with appropriate buffers.  
For a single digestion, 1 µl of restriction enzyme (10U/µl) was used to digest 
0.1 to 0.5 µg of DNA samples. Bovine serum albumin (BSA) was added according to 
the manufacturer’s recommendations and the final volume was adjusted accordingly 
with sterile distilled water. 
All reactions were heat inactivated at 65oC for 20 minutes or by the addition of 
loading dye. 10 µl of the restriction enzyme digestion products were then analysed by 
agarose gel electrophoresis. For each PCR product to be digested, the reactions were 
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first digested with one enzyme, followed by gel electrophoresis (section 2.6) and gel 
purification (Section 2.7) and the second digestion of the PCR product. 
 
2.3.2 Digestion of the plasmid DNA 
For each vector, RE digestions of the plasmid DNA were achieved following 
the same procedure as described above.  
 
2.3.3 DNA ligation 
Ligation of the insert to the vector was done overnight at 4oC. The ratio of 
vector DNA to the insert DNA was between 1:1 to 1:4. This was used to maximize 
the ligation of the insert to the vector. The amount of DNA required was then 
estimated from the agarose gel of the ligated mixture.  
1µl of T4 DNA ligase (3 U/µl) (Promega) was used and 1 µl of 10X ligase 
buffer was used in a 10 µl ligation reaction. 4 µl of the ligation mixture volume was 
used in one single transformation of E. coli TOP 10.  
 In this study, 3a was ligated with pGBKT7 via EcoR1 and Sma1 restriction. 
3A was also ligated to pCMV-myc and pEGFP via EcoR1 and Sal1 restriction.  
 
 
2.4 Preparation of chemical competent E. coli   
A colony of E. coli TOP 10 was grown in a 5ml LB broth and shaken at 
230rpm in a 37oC shaking incubator. 1ml of this starter culture was added into a 
100ml LB broth and shaken at 230rpm in the 37oC incubator until OD600 0.5 -0.6 was 
reached. The tube was then left on ice and incubated for 15-30minutes and spun at 
2,500rpm for 15 minutes in a centrifuge (Beckman CS-15). The pellet was 
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resuspended in 50ml of cold, sterile 50mM CaCl2 and incubated on ice for 20 
minutes. The tube was spun at 2,500rpm for another 15 minutes to pellet the cells and 
the supernatant aspirated. The pellet was resuspended again with 5ml of cold sterile 
50mM CaCl2 cryoprotecting solution (1ml of 100% glycerol + 4ml of 50mM CaCl2). 
Tubes of aliquots of 40µl of competent cells were then stored in a -70oC freezer until 
required. 
 
2.4.1 Transformation of genetic constructs into competent E. coli  
 The 3 genetic constructs were chemically transformed into chemically 
competent E. coli strain TOP 10 and propagated onto Luria Bertani (LB) plates 
(Appendix) containing different antibiotics corresponding to the selection marker on 
the vector. Briefly, 4-5µl of ligated reaction mix (PCR products + vector) were mixed 
with 40µl of chemically competent E. coli TOP 10 cells and incubated on ice for 20 
minutes. The various reaction tubes were then incubated in a 42oC water bath for 60 
seconds and plunged into ice immediately after for 2 minutes. The heat shock step 
enables the bacterial membrane to be more porous for the uptake of the genetic 
constructs. The transformed E. coli were then allowed to recover in 1ml LB broth and 
incubated in a 37oC incubator with 2300rpm for 1 hour.  
100µl - 150µl of the transformed E. coli was then plated on respective LB 
plates containing antibiotics for selection and incubated in a 37oC incubator overnight.    
 
2.4.2 Colony PCR  
Colonies that grew on the LB + antibiotic plates were selected and further 
plated onto another selective LB plate and incubated in a 37oC incubator. PCR 
reactions containing different sets of primer pairs corresponding to the type of gene 
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construct were prepared accordingly and had a generic reaction mix as the PCR 
reactions in Section 3.3. A small dab of the E. coli clone was used as the template 
instead of DNA. The PCR reactions were then subjected to gel electrophoresis in a 
1.6% TBE agarose gel as described in Section 2.7 
 
2.4.3 Extraction of plasmid gene constructs from positive clones of 
E. coli   
 
E. coli clones that showed a positive PCR band with the various primer pairs 
were inoculated into a starter culture of 2-5ml LB medium containing the appropriate 
selective antibiotic and incubated in a 37oC incubator with vigorous shaking 
(~300rpm) overnight.  
This starter culture was then diluted 1/1000 into the selective LB medium and 
incubated in the same incubator for 12 hours for the amplification of the plasmid gene 
constructs. Extraction of the plasmids was carried out using the HiSpeedTM Plasmid 
Midiprep Purification Kit (Qiagen) according to manufacturer’s protocol. The 
extracted plasmid gene constructs were stored in -20oC until required. 
 
 
2.5 CELL CULTURE 
Two mammalian cell lines were used in this study of SARS3A and SARS 
CoV S protein, namely African Green Monkey Kidney Cells (Vero E6) and Human 
promonocytic leukemia (HLCZ). Frozen cell stocks that were stored in liquid N2 were 
thawed in a 37oC water bath and were cultured in DMEM medium containing 10% 
FCS (Vero) and RPMI 1650 medium containing 10% FCS (HLCZ) (Appendix 1). 
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The tissue culture flasks were incubated in a 37oC incubator with 5% CO2 enrichment 
until 70% confluent. The monolayer formed by propagating Vero cells were treated 
with 5X trypsin with EDTA for 3 minutes at 37oC to aid passaging and harvesting of 
cells. The harvested cells were then thoroughly rinsed with 1X sterile PBS, pH 7.4 to 
remove any traces of FCS and spent media and collected in a 15ml centrifuge tube. 
The tubes were then spun in a swing out centrifuge (HERAEUS) for 5 minutes at 
1,800 rpm at room temperature to pellet the cells. The supernatant was discarded and 
the cells resuspended with desired volume of DMEM + 10% FCS media and 
distributed into another sterile 75cm2 tissue culture flask. 
HLCZ cells are suspension cell lines. The propagating cells were transferred to 
a 15ml centrifuge tube and spun in a swing out centrifuge (HERAEUS) for 5 minutes 
at 1,800 rpm at room temperature and supernatant discarded. The pelleted cells were 
resuspended with desired volume of RPMI + 10%FCS and distributed into another 
sterile 75cm2 tissue culture flask. 
 
2.5.1 Adsorption of suspension cells 
HLCZ cells were adsorbed onto 6 well tissue culture plates using BD 
CellTakTM. Coating of the 6 well vessels was performed aseptically in the laminar 
flow hood. The optimal amount of BD Cell-TakTM to be dispensed for coating of the 
wells was calculated according to manufacturing directions and diluted into sterile 
neutral buffer solution containing 0.1M sodium bicarbonate, pH 8.0. NaOH was 
added to attain the coating buffer range of pH 6.5 - 8.0. Typically, the diluted solution 
contains a ratio of 2 (Cell-Tak) : 57 (sodium bicarbonate, pH 8.0) : 1 (1N NaOH). The 
diluted solution was mixed thoroughly and dispensed within 10 minutes. The vessels 
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were then incubated for 20 minutes, and rinsed with sterile water to remove 
bicarbonate, air dried and stored in 4oC. 
 HLCZ cells were then seeded in equal amounts into the coated 6 well tissue 
culture plates. 
 Vero cells are adherent cells and thus do not require Cell-Tak to aid 
adherement. Briefly, resuspended Vero cells were seeded in equal amounts into the 
coated 6 well tissue culture plates. 
 
2.5.2 Seeding of coverslips with Vero E6 and HLCZ cells 
Prior to cells seeding, glass slides and coverslips were washed with methanol 
and dried vertically in 6-well plates (Falcon). For HLCZ cells, the cover slips were 
first coated with Cell-TakTM as described above and air dried. 1ml of Vero and HLCZ 
cells (~70% confluent in a 6-well plate) were seeded onto the cover slips and allowed 
to grow for 4-6 hours in a 37oC incubator with 5% CO2 enrichment. 1ml of media was 
added to compensate for evaporation and left to incubate overnight in the incubator.  
 
2.5.3 Transfection of Mammalian Cells in 6 well plates for 
Immunoprecipitation 
Twenty four hours prior to transfection, 6-well plates were seeded with 2-8 x 
105 cells in 2ml complete medium to be propagated till ~80% the following day. The 
cells were transiently transfected with the mammalian expression vector(s) shown in 
Table 2 using TransFectin (Bio-Rad Laboratories) according to manufacturer’s 
protocols. Optimization of transfection was performed by transfecting Vero E6 and 
HLCZ cells again 4-6 hours after the initial “dose”. For each well, 250µl of serum 
free RPMI was mixed with 3 µg of plasmid DNA and 10µl of TransFectin was mixed 
53 
with 250µl serum free RPMI to be mixed and incubated at room temperature for 20 
minutes. 
 The DNA-TransFectin complexes were then added directly to the cells in 
serum containing medium and gently swirled to ensure even distribution. The 6-well 
tissue culture plates were then incubated in a 37oC incubator with 5% CO2 
enrichment. 
 
2.5.4 Transfection of Mammalian cells for Confocal microscopy 
Cells were seeded onto the sterile Cell-Tak treated coverslips in 6 well plates 
(Falcon) to achieve at least 50% confluency. Transfection was carried out as 
described above but at a reduced quantity according to the manufacturer’s protocol. 
 
2.6  Preparation of samples for Immunoprecipitation 
  After post transfection, the cells were washed once with 1 X sterile PBS and 
incubated with 1ml of 1 X PBS + 0.068M EDTA for ~2 minutes at 37oC per well. 
This allows the cells to lifted and harvested in microfuge tubes and spun at 2,000 rpm 
for 6 minutes in a 4oC centrifuge. The supernatant from the tubes were decanted and 
the cell pellet rinsed with 1 X sterile PBS. Again, the tubes were spun at 2,000rpm for 
6 minutes and the supernatant decanted. 0.5ml of lysis buffer [1 X PBS + 1% Triton X 
(BioRad) + 1 X Protease Inhibitor] was added to each of the microfuge tubes for the 
lysis of the cells and incubated at 4oC for 1-2 hours on a rocking incubator. The 





2.6.1 Western blot analyses of total cell lysates 
Twenty microlitres of the samples prepared above were loaded to each lane 
and separated using a 8-10% polyacrylamide gel electrophoresis in Laemmli running 
buffer (Laemmli, 1970) using a BioRad Mini Protean 3 Cell at 60 mA for 1 hr. 10 µl 
of molecular weight marker (Benchmark TM Protein Ladder, Invitrogen) was loaded 
for each sample run.  
Polyvinylidene difluoride (PVDF) membranes (Biorad, USA) were soaked in 
methanol for 15 sec and then rinsed with ddH2O for 10 minutes. The SDS-PAGE gel, 
PVDF membranes and filter papers were equilibrated with CAPs transfer buffer on a 
shaking incubator for 30 minutes. A sandwich consisting of the sponge, followed by 
filter paper, SDS-PAGE gel, PVDF membrane, filter paper and sponge was assembled 
according to the manufacturer’s protocol. 
The sandwich was placed in the BioRad Mini Protean Cell 3 tank and covered 
with CAPS transfer buffer for electroblotting using the BioRad PowerPack at 40V, 
overnight. 
 After blotting, the PVDF membrane lanes containing protein markers were 
excised neatly and stained with Commassie Blue for 10 minutes. This was followed 
by a destaining step using Destain A for 10 minutes and a further destain by Destain B 
for approximately 30 sec. (Appendix). As for the remaining lanes containing the 
transferred protein lysates, the membrane was blocked with 3% BSA in PBS at 4oC 
overnight with shaking and rinsed with TBST wash buffer ( see Appendix) Each blot 
was incubated with 2-3µg of rabbit anti-Spike polyclonal antibody, rabbit anti-GFP 
antibody and anti c-myc AP conjugated antibody for at 2 hours at room temperature 
with shaking. The solution was decanted and then washed thrice with TBST wash 
buffer for 15 minutes each. Thereafter, the membrane was incubated with goat anti-
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rabbit igG conjugated with alkaline phosphatase (Chemicon, USA) at 1:1000 dilution 
for 1 hour. The solution was decanted and the blots washed thrice with TBST wash 
buffer 15 minutes per wash. The membranes were overlaid with alkaline phosphatase 
activating buffer (Appendix) for 30 minutes with shaking. After decanting, 
BCIP/NBT colour development solution (Appendix) was mixed with colour 
development buffer at 1:1:100 and poured over the PVDF membrane in the dark for 
5-20 seconds. Any immunoreactive bands would have been easily visualized.     
 
2.6.2 Indirect imunofluorescence labelling 
Twenty-four hours post transfection of the cells on the cover slips, the culture 
medium of the transfected cells was carefully aspirated and the cells washed once 
with 1X PBS at room temperature with shaking. The cells were then fixed with 2-3 
mls methanol and placed in a -80oC freezer for 4-5 minutes, followed by incubation in 
a -20oC freezer for a further 4 minutes. Thereafter, the cells were incubated in room 
temperature for 3 minutes. The fixative was decanted and excessive fixative removed 
by washing the cells 5 times with 1X PBS. 
SARS-Spike pAb was diluted 1:50 to a 5-10µg/ml concentration, mixed 
reconstituted in Fluorescent Dilution Buffer. The microcentrifuge tube was then spun 
at 12,000 rpm for 5-10 minutes. 30µl of the diluted antibody was spotted in a six well 
plate. Coverslips seeded with cells transfected with pEGFP-Spike plasmid were then 
inverted over the drop of primary antibody and incubated for 1 hour at room 
temperature in the dark. Excess antibodies were then washed off thrice with 1X PBS 
for 5 minutes each at room temperature with shaking. 
Concurrently, isotype specific secondary antibodies labeled with Rhodamine 
were diluted and mixed with FDB till 10µg/ml concentration and spun at 12,000 rpm 
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for 10 minutes. The secondary antibody was then spotted in a sterile six well plate. 
The coverslips were then inverted over the drop of secondary antibody and incubated 
for 1 hour at room temperature in the dark. Excess secondary antibodies were washed 
six times with 1X PBS.  
A single drop of mounting media (Vectashield with DAPI ) was placed on 
methanol-cleaned flass slides and the coverslips inverted over the drop of mounting 
media. Excess Vectashield was blotted with lint-free paper (Kimwipes, Kimerbly 
Clark, Canada) and the edges of the coverslips sealed with two applications of nail 
varnish. Fluorescence was visualized under a confocal microscope (LSM 510, Zeiss, 
Germany or Fluoview 500, Olympus, Japan). FITC and Rhodamine emits green and 
red fluorescence respectively.  
  
2.7 Extraction of RNA from transfected cells 
Total cellular RNA was extracted using the SV Total RNA Isolation Kit 
(Promega) following the manufacturer’s protocol. Briefly, to obtain transfected 
cellular RNA, pelleted cells were washed with ice cold sterile 1X PBS and spun at 
1800 rpm for 5 minutes and the supernatant was discarded. 175µl of SV RNA Lysis 
Buffer was added to the cells and passed through a 20 gauge needle to shear the 
genomic DNA for 4 to 5 times. The lysate was expelled into a 1.5ml tube. 350µl of 
SV RNA Dilution Buffer was added and the tubes mixed 3-4 times. This was placed 
in a preheated water bath at 70oC for 3 minutes and spun at 12,000-14,000 rpm for 10 
minutes in a micro centrifuge.  
The cleared lysate solution was transferred to a fresh microcentrifuge tube by 
pipetting, followed by 200µl of 95% ethanol. This was transferred to the Spin Column 
Assembly and spun at 12,000-14,000 rpm for one minute in a micro centrifuge. A 
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DNase solution (refer manufacturer’s protocol) was added and incubated in room 
temperature for 15 minutes. 200µl of DNase Stop Solution was added to stop the 
reaction and spun at 14,000 rpm for 1 minute. The trapping membrane in the column 
was washed twice with SV RNA wash solution to eliminate traces of left over DNase 
solution. The trapped RNA was rehydrated with 100µl Nuclease Free-Water and 
centrifuged again at 14,000rpm for 1 minute.  
The integrity of extracted total cellular RNA was assessed by running 0.5µg of 
RNA on a denaturing formaldehyde-agarose (FA/ethidium bromide gel) (Appendix). 
The presence of 2 bright, degined bands corresponding to the 28S(~5kb) and 18S 
rRNA (~2kb) bands confirms the integrity of the cellular RNA. 
 
2.7.1 Nucleic acid quantification 
The amount and purity of the isolated RNA and plasmids generated by 
Plasmid MidiPrep was measured by spectrophotometry. An appropriate dilution of the 
nucleic acid was prepared using nuclease free ddH2O and read in a spectrophotometer 
(Shimadzu-UV 1601, Australia) at wavelengths 260nm and 280nm. An absorbance of 
1 O.D unit at 260nm of RNA is equivalent to 50µg/ml of total RNA.  
 
2.8.0 DNA MICROARRAY STUDIES 
Gene expression studies were performed using the BD AtlasTM Human 3.8I 
and 3.8II cDNA panel (BD Biosciences, USA) which comprises of total of 7,600 





2.8.1 Total RNA Preparation for Microarray 
Vero E6 cells were transfected with pEGFP-S and mock transfected with 
pEGFP only as described in Section 2.5.3 but in a tissue culture flask. Concurrently, 
HLCZ cells were transfected with pCon-S-Harv-myc-his (a Harvard construct on a 
pCDNA3.1 backbone which expresses the extracellular domain of the SARS-CoV 
Spike protein. This construct was kindly obtained from Dr. Lu’s lab) as well as a 
mock dual transfected with pCDNA3.1 as a control. Total cellular RNA was extracted 
from transfected cells using SV Total RNA isolation kit (Promega) as described 
above. 
 
2.8.2 Preparation of cDNA probe 
To prepare the cDNA probes for both the cells types, the CyScribe Post-
Labelling Kit (Amersham Biosciences) was used for the preparation of Cy3 and Cy5 
labelled cDNA probes. This involved a two step procedure:-  
1) incorporation of aminoallyl-dUTP (AA-dUTP) during cDNA synthesis 
using an optimized mix followed by 
2) chemical labeling of the amino allyl modified cDNA using CyDye NHS-
esters.  
50µg of total RNA was mixed with 1µl random primers, anchored oligo dT in 
a sterile 1.5ml microcentrifuge tube on ice and incubated in a waterbath at 70oC for 5 
minutes. The reactions were allowed to cool. To each reaction tube, 4µl of 5x 
CyScript buffer, 2µl 0.1M DTT, 1µl Nucleotide mix, 1µl AA-dUTP and 1µl of 
CyScript reverse transcriptase (all reagents were included in the kit) were added and 
mixed by gentle pipetting. They were incubated at 42oC for 1.5 hours and stored at -
20oC for further use. 
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2.8.3 Purification of amino allyl modified cDNA 
Following the synthesis of cDNA incorporated with AA-dUTP, the modified 
cDNA was purified by first degrading mRNA followed by the purification of cDNA 
with CyScribe GFX Purification kit.  
To each tube containing AA-dUTP modified cDNA, 2µl of 2.5M NaOH was 
added and mixed by vortexing and incubated in a waterbath at 37oC for 15 minutes. 
10µl of 2M HEPES free acid was added to each reaction and mixed and stored at -
20oC until further use. This was transferred to a GFX column and 500µl of capture 
buffer was added and gently pipetted 5 times and spun in a centrifuge at 14,000 rpm 
for 30s. 600µl of 80% ethanol was added to each column and spun at 14,000 rpm for 
30s again. This wash step was repeated 3 times and eluent discarded. Following 
another 10s of centrifuge to remove all traces of the 80% ethanol, the column was 
placed in a sterile 1.5ml microcentrifuge tube. 60µl of 0.1M Sodium bicarbonate was 
added, completely overlaying the glass fibermatrix membrane of each GFX 
purification column and incubated at room temperature for 5 minutes. Thereafter, the 
tubes were spun at 14,000rpm for 1 minute to collect the purified AA-dUTP cDNA. 
 
2.8.4 Labelling of amino allyl-modified cDNA with CyDye 
The purified cDNA reactions were each added into one aliquot of CyDye NHS 
in a 1.5ml tube and resuspended gently. After spinning at 14,000rpm for 1 minute, the 
reactions were incubated in the dark at room temperature for 90 minutes. Thereafter, 
15µl of 4 M hydroxylamine was gently added to each coupling reaction and incubated 
in the dark at room temperature for another 15 minutes. Again, purification of the 
labeled cDNA was carried out using the GFX columns. 
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2.8.5 GFX purification of CyDye labeled cDNA 
The unpurified labeled cDNA producs is transferred to each GFX column and 
mixed gently for 5 times. Each reaction is then centrifuged at 14,000 rpm for 
30seconds and the effluent removed. 600µl of wash buffer was added to each column 
and spun down again. This wash step was repeated for a total of 3 washes and spun 
again to remove the wash buffer in the column. Each of the tubes was placed in a 
sterile 1.5ml microcentrifuge tube. 60µl of preheated elution buffer was overlaid on 
the glass fiber matrix. After incubation at room temperature for 5 minutes, the column 
was spun at 14,000 rpm for 1 minute and collected. The purified cDNA was measured 
for Cy5 dye at 659nm and Cy3 dye at 550nm in a UV spectrophotometer 
The amounts of Cy3- and Cy5-labelled cDNAS were measure at absorbances 
of 550nm and 650nm respectively and calculated based on the formula: 
(absorbance/extinction coefficient) x colume of cDNA x dilution factor x 1012. The 
extinction coefficients for Cy3 and Cy 5 were 150,000 and 250,000mol-1cm-1 
respectively. 
   
2.8.6 Hybridization of cDNA Probe with Array Slides 
The appropriate amount of labeled cDNA probes were mixed with 2.1 ml 
prewarmed (50oC) GlassHyb Hybridization Solution and gently mixed by pipetting. 
This was slowly pipetted into the Hybridization Chamber with the enclosed glass 
array to prevent foaming and the wide sides of the chamber squeezed slightly to 
eliminate excess air. The chamber was allowed to hybridize overnight (of at least 17 
hours) in an upright position in a 50oC incubator. Thereafter, each glass slide was 
immersed into Wash 1 (Appendix) consisting of 22ml BD GlassHyb Wash solution 
for 10 minutes and immediately transferred into Wash 2a (Appendix) for another 10 
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minutes and again into Wash 2b (Appendix) for a further 10 minutes and then in 
Wash 3 (Appendix) followed by a brief rinse in sterile deionized water. The glass 
slide was then placed in a dry wash container and spun in a swing out centrifuge at 
1,500 rpm for 5 minutes to remove any traces of water. 
 
2.8.7 Scanning of labeled Array Slide 
The slides were scanned for Cy3 and Cy5 signals with a dual color image 
scanner GenePix 4000B (Axon Instruments, Molecular Dynamics) and the raw data 
were analyzed using Acuity software version 3.0 (Axon Instruments). Stringency was 
excercised by flagging individual spots of poor quality (extreme unevenness in signals 
and streaks) that were omitted from Acuity and MIDAS software analyses. An initial 
low intensity filtering based on 30% of the standard deviation of the total background 
intensity was performed following the MIDAS software analysis. This criterion 
allows for the effective disregard of the low intensity spots while retaining those of 
sufficient quality to be analyzed. 
The filtered data was normalized against the Cy5-labelled uninfected HLCZ 
cDNAs as the reference by using locally weighted linear regression (LOWESS) 
analysis to remove intensity-dependent effects found in log2 ratio values (Yang et. al., 
2002).  
Following that, regularization of the standard deviations of the normalized 
data was performed to adjust for the variance of the measured log2 ratio values to be 
similar throughout the entire array, minimizing variability of the results. The values 
were then subjected to SLICE analysis that defined the intensity dependent Z-score 
threshold to be greater than 1.96 (equivalent to more than 1.96 standard deviations 
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from the mean of values) that allows the identification of genes that were 
differentially expressed at the 95% confidence level. 
 
3.0 REAL TIME PCR (RT-PCR) FOR VALIDATION OF 
MICROARRAY RESULTS 
 
3.1 Total RNA preparation for RT-PCR 
The total RNA was extracted and purified from untransfected and transfected 
Vero E6 and HL-CZ cells using the SV total RNA isolation kit (Promega) and 
resuspended in nuclease-free water. Quantification was carried out with UV 
spectrophotometry (Nanodrop) at 260nm.  
 
3.1.1 cDNA synthesis using reverse transcription and real time RT-
PCR using SYBR green detection 
The extracted Total cellular RNA (5μg) was first treated with DNAase with the 




Volume added per 
reaction tube 
Total cellular RNA 5μg
DNAse Buffer 5μl
DNAse  
(Invitrogen Amp grade) 
1μl
H2O Top up to 50μl
   
The reaction tube was then incubated in room temperature for 30 minutes followed by 
a heat block at 80oC for 10 minutes to inactivate the DNAse. 
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Following which, the RNA was reverse transcribed in a 100μl reaction mix containing 




Volume added per 
reaction tube 
Total DNAse treated RNA 50μg from above 
10X RT buffer 10μl 









dd H2O 33μl 
 
The reactions were incubated at 37oC for 1 hour followed by 95oC for 5 minutes. The 
Synthesized cDNA was then re-quantified by UV spectrophotometry (Nanodrop), 
aliquoted and stored at -80oC.  
 
Expression levels of the 5 genes that were selected following microarray 
analysis were further validated by real-time RT-PCR using SYBR green detection. An 
aliquot of the cDNA was subjected to RT-PCR using an iCycler iQ fluorescence 
thermocycler (Bio-Rad, Hercules, CA) with the iQ SYBR green SUPERMIX kit (Bio-
Rad). The conserved HUEL gene was included in the real-time RT-PCR analysis as a 
housekeeping gene transcript to normalize the samples. Each 10-μl reaction included 
10ng of cDNA, 1mM of each RT-PCR primer, 2μl of ddH2O and 15μl of iQ SYBR 
green SUPERMIX.  PCR conditions included denaturation at 95oC for 5 minutes and 
then for 40 cycles of 95oC for 30s, 50-55oC for 45s, and 72oC for 30s, followed by 5 
minutes at 72oC for elongation. Amplified products were analyzed for specificity by 
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agarose gel electrophoresis. All RT-PCR primers were using the oligonucleotide 
software PrimerSelect (DNASTAR) and were designed based on the nucleotide 
sequence of the genes found in humans. Table 4 lists the nucleotide sequence of the 
primers designed and used in this real time RT-PCR. 
To ensure the reproducibility and to test the robustness of our RT-PCR 
system, triplicate reactions were performed and the mean CT values obtained from 
each tube were used for calculating relative expression levels. For each gene of 
interest, the difference between their CT values (∆CT) was determined and their ∆CT 
value subtracted from the ∆CT value of HUEL. This then gives rise to ∆∆CT. Finally, 
the 2-∆∆CT value was calculated which reflects the relative expression levels for each 
sample over HUEL.





Gene          Primer Sequence (5 3')   Target size (bp) 
           Sense   Antisense     
Homo sapiens solute carrier organic anion transporter family,     






             
Major histocompatibility complex, class I, A,  AGCGGGATGGGGAGGAC  AGGGGCTTGGGCAGACC  157 
             
Retinoblastoma-like 1 (p107) (RBL1), transcript variant 1  CACGAAGCCGGAAGCAGAGG  AGTCATCCCCAATCATCCGAAAAT  111 
             
Interleukin 8 receptor, beta (IL8RB)   CCCCATGTGAACCAGAATCC  GCAAGGTCAGGGCAAAGAGTA  195 
             
Beta actin        CAATGTGGCCGAGGACTTTG   CAT TCT CCT TAG AGA GAA GTG G   127 
           
Table 4: The primers listed on this table were generated using PrimerSelect software (DNASTAR) and designed based on the cDNA sequence    
 of the 5 genes found in the NCBI database. To ensure that the real time PCR was specific, all the primers were designed to amplify fragments    






















4.0 Characterisation of protein 3A constructs used in the study 
 
4.1 Expression of protein 3A constructs for Y2H as baits  
The SARS-CoV protein 3A is encoded by a 825bp full length transcript 
corresponding to 25268 – 26092nt of the SARS CoV genome. In order to generate 
expression constructs that contains the transcript for 3A to be used for the yeast two 
hybrid experiments, we first amplified the cDNA fragment using RT-PCR with 
oligonucleotides SARS3AF1a and SARS3AR1. These primers were designed with 
flanking restriction enzyme sites to generate a PCR fragment that contains RE overhangs. 
The fragment was cloned into PCR XL-TOPO via PCR and transformed into competent 
E.coli TOP 10 cells for increased amplification of the 3A gene. Sequencing of the 3A 
gene using primers M13F and M13R showed a single mutation of a Guanine residue to an 
Adenine (Fig 4). All sequencing results were performed at least thrice for purpose of 
confirmation. The mutation was a genuine change.   
Following extraction of genomic DNA from the transformed E.coli TOP 10 cells, 
the 3A construct amplified with SARS3AF1a and SARS3AR1 was restricted and 
subsequently cloned into the yeast expression vector pGBKT7, creating another construct 
termed 3A-pGBKT7 (Fig 5). Agarose gel electrophoresis showed the presence of 3A-
pGBKT7 as a ~8.1kB band (Fig. 6). To ensure that the construct would be translated and 
expressed, sequencing using T7 primers was performed thrice and confirmed that the 3A 






The bait and the prey 
pGBKT7 is a DNA binding domain vector that encodes amino acids 1–147 of the 
GAL4 protein and contain a Tryptophan (Trp) marker. The construct 3A-pGBKT7 was 
transformed in S. cerevisiae Y190 by the lithium acetate procedure and plated onto 
minimal, synthetic dropout medium lacking tryptophan (SD/-Trp) using the Matchmaker 
Yeast Two Hybrid Systems from Clontech (Palo Alto, CA, USA). Colonies which grew 
on these plates were able to survive the selection and contained the pGBKT7 plasmid. 
Colony screening through sequencing were performed to further select for clones that 
contained the 3A-pGBKT7 construct. These colonies which contain the GAL4-3A-
pGBKT7 construct served as a bait gene with fusion to the DNA-BD.  
pGADT7 is the plasmid that consists of a Leucine (Leu) marker and the activating 
domain (AD) and allows expression of a second hybrid protein or cDNA library that is 
fused to amino acids 768–881 of the GAL4 activation domain. This construct can be 
brought into close proximity with the DNA binding domain of GAL4-3A-pGBKT7 during 
mating of the 2 yeast constructs, effecting activation of the reporter LacZ gene 
downstream. In this study, pretransformed yeast colonies containing the human cDNA 
library expressed as a fusion to the AD was purchased from BD Biosciences to serve as 
the prey.  However, despite repeated replacements, we were unable to obtain any live 
yeast prey containing the cDNA library. Unfortunately, much time was spent soughting 
for a working library prey without any success and it was regrettable that the author was 
unable to proceed with any mating experiments. 
To ensure that the above experiment was carried out properly according to the 
manufacturer’s protocol, a positive control was prepared with pGBKT7-53, which 
expresses murine p53 fused with the GAL 4 DNA BD and pGADT7-T, expressing the 
SV40 large T-antigen fused to the GAL 4 AD (the proteins interact in vivo in a yeast two-
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hybrid screen). Transformation yielded many positive colonies that were able to grow in 
SD/-Leu/-Trp/-His medium. These clones were grown at 30ºC for 8 to 10 days and then 
streaked in SD/-Leu/-Trp/-His/-Ade/X-α-GAL medium to verify the activation of all the 
reporter genes (ADE2, HIS3 and LacZ). These transformants were then streaked on plates 
with SD/-Leu/-Trp/-His/-Ade medium containing X-α-GAL. Reconstitution of GAL 4 
activity restored during the mating of the 2 transformed yeast strains enabled the 
transformants to grow under the harsh conditions and to detect expression of HIS3, ADE2 


































5’ frame 1:- 
Met D L F Met R F F T L G  Å mutated nt causing a change in amino acid residue 










Figure 4. Diagram of the chromatogram signal from sequencing highlighting 
the point mutation at the nt 31 of protein 3A. A native Adenine has 
replaced Guanine, causing a change in the amino acid residue. All 
sequencing results reported in this study were performed at least 









    













Figure 5 .   Schematic diagram of the construction of 3A gene insert fused with c-
Myc tag restricted on EcoR1 and Sal1 in pGBKT7 vector. Plasmid 


















Figure 6 .   Agarose gel electrophoresis photograph of SARS 3A insert and 
pCMV-Myc vector construct. Lanes: M, 1kb DNA marker; 1, empty 
lane; 2, uncut pGBKT7 plasmid; 3, 3A-pGBKT7 ligated construct; 4, 
uncut pCMV plasmid; 5, 3A-pCMV ligated construct; 6, Spike-
pEGFP ligated construct; 7, uncut pEGFP plasmid; 8, PCR product of 





800bp SARS 3A 
~825bp 
M 1 2 3 4 5 6 7 8 9 
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4.1.1 Using recombinant pCMV-Myc3A to study the effect of SARS-CoV 3A 
protein in mock infection of Vero E6 cells 
 To obtain a construct that would express protein 3A in mammalian cells, the full 
length fragment of 3A protein generated by oligonucleotides SARS3AF1b and 
SARS3AR1b1, was fused to the N terminal c-myc tag and cloned into the MCS of the 
pCMV-Myc vector (BD Clontech). The c-myc epitope tag is well-characterized and highly 
immunoreactive. High-level expression in mammalian cells is driven from the human 
cytomegalovirus immediate early promoter/enhancer (PCMV IE).The vector also posses the 
polyadenylation signal from SV40 as well as the ampicillin resistance gene which allows 
selection of ampicillin resistant clones when transformed into E. coli for amplification of 
the plasmid construct.. The result of the fusion produced a recombinant plasmid of ~4.6kb 
band on agarose gel electrophoresis (Fig 6 Lane 5) and was transformed into competent 
E. coli for selection in ampicilin-enriched media. Following transformation and 
amplification of the recombinant construct in competent E. coli, the construct was 
sequenced using flanking vector sequencing primers both upstream and downstream of 
the insert to ensure that the protein 3A insert was inframe and fused to the rest of the 
vector backbone. PCR followed by cycle sequencing was carried out with pCMV forward 
and reverse sequencing primers (BD Clontech) using purified plasmids harvested from 
the E. coli as templates. 
Following PCR amplification of protein 3A from purified recombinant plasmids, 
site directed RE digest with EcoRI and SalI released the full-length protein 3A from the 
rest of the pCMV-Myc plasmid (Fig 6a). The expected sizes were 800bp and 3.8kb (Fig 
7). To mimic SARS-CoV infection, VeroE6 cells were transfected with the 3A construct 
plasmid packaged in Transfectin (BioRad Laboratories). Sequencing of pCMV-myc-3A 
construct was performed using T7 primers upstream and downstream of the MCS 
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junction. The 3A gene was in frame.  However, expression of pCMV-3A was not detected 
and no visible precipitation was detected in reducing SDS-PAGE using anti-cMyc 
antibodies (Data not shown).   
 
 
    










Figure 6a .   Schematic diagram of the construction of 3A gene insert fused with c-
Myc tag restricted on EcoR1 and Sal1. at the MCS of pCMV-Myc 
















Figure 7 .   Agarose gel photo of SARS 3A insert and pCMV-Myc vector 
construct following RE digestion of purified PCR product amplified 
from recombinant plasmid with EcoR1 and Sal1. Lanes: M, 1kb DNA 





4.2 Characterisation of SARS-CoV S protein constructs used in the 
study 
 
4.2.1 Transfection of Vero E6 and HEK 293T cells to determine the expression of 
SARS-CoV S protein in mammalian cells. 
The full length S protein (1,255 amino acid residue) is a crucial protein in the 
virulence of SARS and was amplified by RT-PCR from SARS viral RNA and cloned into 
PCR XL-TOPO using primers SpikeF and SpikeR. The resulting fragment was then TA-
cloned and subsequently transformed into competent E. coli Top 10 for amplification of 
the Spike gene. Repeated sequencing showed that when compared to the complete 
genome NC_004718, the PCR amplified insert had 4 mutations. At position 612nt, a point 
mutation of Thymidine to Cytosine; at 1729nt, a Guanine to Thymidine. At 1956nt, a 
Thymidine to Guanine and at 3413nt, a mutation from Thymidine to Cytosine. The first 
three mutations are silent . 
To determine the expression of the Spike protein, it was first amplified in a PCR 
reaction using primers SpikeXhoIF and SpikeBamHIR and then restricted cloned 5’ of the 
EGFP protein of the pEGFP vector (BD Clontech) (Figure 9). This produced a ~7.2kb 
recombinant plasmid which expressed a fusion Spike-EGFP protein. Vero E6 cells lysates 
transfected with the recombinant plasmid were analyzed with 10% reducing SDS-PAGE 
using anti human Spike monoclonal antibodies (Crucell, Netherlands). In addition, human 
embryonic kidney HEK293T cells were concurrently transfected with the Spike construct. 
Western blot analyses revealed the presence of SARS CoV Spike protein was detected in 
both Vero E6 and HEK 293T cell pellets. Interestingly, a strong signal of Spike protein 
















Figure 8.   Agarose gel photograph of Full length Spike-pEGFP ligated 
constructs. Lane M, 1kb DNA Ladder; 1, pEGFP plasmid vector only; 
2, recombinant Spike-EGFP plasmid band.   
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Figure 9.   Schematic diagram of the construction of the SARS-CoV Spike gene 
insert at the 5’ MCS site fused with an EGFP tag restricted on XhoI 
and BamHI the pEGFP vector. Plasmid diagram taken from Clontech, 


































Figure 10 .   Western blot analysis of SARS CoV Spike protein in total cell lysates 
and cell pellet of HLCZ cells. Bands of the SARSCoV-Spike protein were detected 
using anti-Spike monoclonal antibody. Lane M,  Prestained Kaleidoscope Protein 
ladder (Bio-Rad); 1, Lysates of HLCZ cells transfected with only the pcDNA3.1 
plasmid;  2, Lysates of HLCZ cells transfected with Spike construct;  3, cell pellet 
from pcDNA3.1 transfection; 4, cell pellet from HLCZ transfected with the Spike 
construct. In Lanes 2 and 4, a ~180kDa band was precipitated when probed with 













4.2.2 Characterisation and expression of codon optimized Spike construct, pCon-S-
Harv-Myc-His, in transfected HLCZ cells 
The construct pCon-S-Harv-Myc-His was obtained from Harvard University 
(courtesy of Dr. Zhong Fei, NUMI, personal communication) which contained a codon 
optimized ectodomain of the SARS-CoV S protein for mammalian cells. Briefly, it was 
constructed on a pCDNA3.1 vector with a double tag of Myc and His and contains the 
extracellular domain of the Spike protein. 
 Babcock and colleagues have demonstrated the construction of a codon optimized 
Spike protein sequence which was demonstrated to be more effective during transfection 
in mammalian cells for the expression of Spike protein and replaced the natural codons 
with the following optimum codons: alanine (GCC), argine (CGC), asparagines (AAC), 
aspartic acid (GAC), cysteine (TGC), glutamic acid (GAG), glutamine (CAG), glycine 
(GGC), histidine (CAC), isoleucine (ATC), leucine (CTG), lysine (AAG), methionine 
(ATG), phenylalanine (TTC), proline (CCC), serine (TCC), threonine (ACC), tryptophan 
(TGG), tyrosine (TAC) and valine (GTG). (Babcock et al., 2004).  
 HL-CZ is a human promonocytic leukemia cell line (BCRC: 60043), which 
possess CD15, CD34 and CD11b markers and used frequently in the cultivation of the 
Dengue, influencza virus type A and HIV-1. Two batches of HLCZ cells (kindly obtained 
from Dr. Lu Jinhua, NUMI) were grown to ~90% confluency before replacing with serum 
free maintenance medium. One batch of HLCZ cells was transfected with pCon-S-Harv-
Myc-His at 24 hr after cell seeding. A second transfection with the spike construct was 
performed 4 hours later in this batch. The second batch of HLCZ cells was concurrently 
transfected with the control plasmid pcDNA3.1 Both batches of cells were then harvested, 
lysed and analyzed by 10% reducing SDS-PAGE. Using monoclonal antibodies to SARS 
CoV Spike protein, a large band of ~180kDa band was revealed in the total cell lysate and 
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cell pellet of the batch of cells which were transfected by SARS CoV Spike (Fig. 10). 
Total cell lysate and cell pellet from the second batch of HLCZ cells that were transfected 
by control pcDNA3.1 plasmid did not show any precipitation of protein bands, thus 
























































Figure 11 .   Western blot diagram of the SARSCoV-Spike protein using 
monoclonal Ab on Vero E6, HLCZ and HEK293T cell supernatants 
and cell lysates. Lane M, Kaleidoscope protein ladder; 1, supernatant 
from Vero E6 transfected cells with the Spike construct; 2, Lysates 
from Vero E6 cells transfected with Spike construct; 3, Supernatant 
from HLCZ cells transfected with Spike construct; 4, HLCZ cell 
lysates showing Spike expression; 5, Supernatant from HEK293T cells 
transfected with Spike construct; 6, HEK293T cell pellet expressing 
Spike protein; 7, HLCZ cells transfected with control pcDNA3.1 















4.2.3 SARS-CoV S protein is expressed in HLCZ cells  
 To visualize the intracellular distribution of the S protein, two batches of 
HLCZ cells were grown to~90% confluency in T25 tissue culture flasks (Nunc). At post 
24 hr after confluent growth, the HLCZ cells were seeded onto CellTak (BD Biosciences) 
coated glass coverslips and allowed to incubate for 6 hrs. Coating with CellTak enabled 
HLCZ cells to adhere onto the glass coverslips, forming a mock monolayer, allowing for 
increased transfection with Transfectin (Bio-Rad) and multiple washing steps involved in 
confocal microscopy to be performed wit minimal loss of cells. 
One batch of HLCZ cells was transfected with pCon-S-Harv-Myc-His while 
another batch was transfected with the control plasmid, pCDNA3.1. At 24hr post 
transfection, both batches of HLCZ cells were incubated with rabbit anti-SARS CoV S 
polyclonal antibody labeled with Rhodamine. DAPI counterstaining was used to highlight 
cell nucleus. Immunostaining using the antibodies revealed that the cytoplasm of HLCZ 
cells carried the most intense staining for the Spike construct (Fig 13). Interestingly, this 
effect is relatively more pronounced in Vero E6 cells (Fig 12) suggesting that Vero E6 
cells were more susceptible to SARS CoV transfection. 
The intense staining seen in the cytoplasm of transfected HLCZ cells could 
possibly be attributed to the localization of the Spike construct in smooth membrane 
vesicles or sER during transfection. In comparison between the distribution of expression 
of Spike construct in transfected Vero E6 and HLCZ cells, a larger population of staining 
in Vero E6 cells was observed. This could be due to the adherent property of Vero E6, 





Recent studies using confocal microscopy showed that protein subunit C of SARS 
CoV spike protein was localized in the cytoplasm of Sf-9 cells and detection sensitivity 
showed that the spike protein-based IFA was able to detect SARS-CoV specific antibody 
at a lower dilution as compared to commercial IFAs (Manapo et al., 2005) while others 
have been able to locate the Spike expression to be at the cell membrane. In our findings, 
we observed the wide distribution of Rhodamine in the cytoplasm of the cells transfected 
with pCon-S-Harv-Myc-His in Vero E6 cells. (Figure 12).  
Similarly, there was there was clear observation that the Spike protein was 
expressed on HLCZ cell cytoplasm (Figure 13). This suggests that the spike protein that 














Figure 12 Intracellular distribution of Spike protein in transiently transfected 
Vero cells 24 hours post-transfection. (a) cells transfected with pCon-
Spike-Harv-Myc-His and stained with DAPI showing the nucleus. (b) 
cells transfected with pCon-Spike-Harv-Myc-His but probed with α-









Figure 13 Distribution of Spike protein in transiently transfected HLCZ cells 24 
hours post-transfection. (a) cells transfected with pCon-Spike-Harv-
Myc-His and stained with DAPI showing the nucleus. (b) cells 
transfected with pCon-Spike-Harv-Myc-His but probed with α-Spike 
pAb and labeled with Rhodamine. (c) composite diagram of (a) and 
(b) Expression of the Spike protein are localized in the cell cytoplasm 





5.0 Data obtained from cDNA-microarray analysis revealed several 
differential regulated genes in HLCZ post transfection of pCon-
Spike-Myc-His 
Following microarray hybridization (BD AtlasTM Glass Human 3.8I and 3.8II 
Microarray slides), the slides were scanned for Cy3 and Cy5 with a dual color image 
scanner. The majority of signals from slide II were of relatively high intensity. 
Optimization of the labeling of first-strand cDNA with amino allyl-dUTP and purification 
of the CyDye-labelled cDNA prior to hybridization steps were observed to perform more 
efficiently with the CyScribe Post-Labelling Kit with Cyscribe GFX Purification Kit 
(Amersham Biosciences)    
In both slides 1A and 2A of the gene array, Cy3 dye was incorporated into the 
total RNA extracted from cells transfected with pCon-Spike-Myc-His while Cy5 dye 
incorporated into the total RNA extracted from cells transfected with pCDNA3.1 followed 
by hybridization of the slides as described previously. 
A swap dye reaction was performed with Slide 1B where Cy5 dye was 
incorporated into the total RNA extracted from cells transfected with pCon-Spike-Myc-
His and Cy3 dye incorporated into the total RNA extracted from cells transfected with 
pCNDA3.1 followed by slide hybridization. This allowed for the comparison of efficiency 
of Cy-Dye uptake as well as served as an authentication of the microarray data. 
Although the majority of the scanning signals were of weak intensity in slide 1, 
there were some spots that showed strong intensity. While scanning the gene array slides 
(Genepix 4000B, Axon Instuments), low quality spots (extreme unevenness in intensity) 
were flagged off in the analysis software Acuity. This allowed us to retain spots that had 
sufficient signals. Log2 values obtained from the scanning of the Cy3 labelled Spike 
transfected HL-CZ cellular cDNA were then normalized against values from Cy3-labelled 
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pCDNA3.1 transfected HL-CZ using locally weighted linear regression (LOWESS) 
analysis. When the transcript levels of both recombinant Spike construct and pCDNA3.1 
control vector transfected cells were compared, a total of 3,756 genes were found to 
exhibit differential gene expressions. Genes with a scan log2 ratio (Spike infected HL-CZ 
against pCDNA3.1 infected HL-CZ) of above 1.5 or below 0.5 suggested significant up 
regulation or down regulation of the genes respectively. These values were then translated 
to gene expression in actual folds by the following 2X where x represents the log2 value 
generated by Acquity. The filtered data was normalized by using LOWESS analysis and 
we defined a threshold to be greater than 1.96 (i.e. equivalent to those more than 1.96 
standard deviations from the local mean) based on the duplicated set, which permitted us 
to identify 102 genes that were differentially expressed at the 95% confidence level. Of 
these, 61 transcripts were found to be significantly up regulated while 41 genes 
demonstrated a decrease in expression level greater than 2-fold based on Acuity analysis. 
Table 5 groups the transcripts that were significantly altered at 24 hours post transfection 
according to their known function including mRNA of 26 gene transcripts of little or no 
known function. 
Genes with altered transcriptional patterns belonged to a wide range of functional 
classes. For example, those involved in intracellular host signaling or modulation, 
transcription were generally upregulated. In contrast, genes involved in cell metabolism 
and cytoskeleton formation were notably downregulated. The transcripts of other 
functional categories exhibited varied reponses to SARS CoV Spike transfection. 
 
    89 
Table 5: Categories of Human Genes showing altered levels of transcription following transfection with pCON-Harv-S-Myc-His in 
HLCZ 
    
Gene Classification Gene 
Levels of 
Transcriptional  Genbank accession no 
    changes (fold ∆)    
    
Cell cycle  stem-loop (histone) binding protein (SLBP), mRNA 2.18 ↓ NM_006527 
and development 
proteins histone 1, H4i (HIST1H4I), mRNA 2.14 ↑ NM_003495 
 histone deacetylase 5 (HDAC5), transcript variant 1,  mRNA 2.18 ↑ NM_005474 
 retinoblastoma-like 1 (p107) (RBL1), transcript variant 1, mRNA 2.74 ↑ NM_002895 
 serum-inducible kinase mRNA, complete cds 2.78 ↓ AF059617 
 cyclin A1 mRNA, complete cds 3.95 ↑ U66838 
 prothymosin alpha mRNA (ProT-alpha), complete cds 6.37 ↑ M26708 
    
Intracellular 
transducers/modul
ators lysosomal associated multispanning membrane protein 5(LAPTM5), mRNA 3.25 ↓ NM_006762 
 angiomotin like 2 (AMOTL2), mRNA 2.15 ↓ NM_016201 
 netrin 1 (NTN1), mRNA 2.10 ↑ NM_004822 
 cysteine and glycine-rich protein 1 (CSRP1), mRNA 2.19 ↑ NM_004078 
 RAS, dexamethasone-induced 1 (RASD1), mRNA 4.13 ↑ NM_016084 
 patched homolog (PTC) mRNA, complete cds 2.53 ↓ U43148 
 mRNA for protein kinase C-Epsilon 2.12 ↓ X65293 
 cysteine protease Mch2 isoform beta (Mch2) mRNA, complete cds 2.11 ↓ U20537 
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 mRNA for adenylyl cyclase 2 2.11 ↑ X74210 
 gas1 gene, complete cds 2.30 ↑ L13698 
 cdc2-related protein kinase mRNA, complete cds 2.51 ↑ M68520 
 DNase I mRNA, complete cds 2.69 ↑ M55983 
 guanine nucleotide regulatory protein (tim1) mRNA, complete cds 2.80 ↑ U02082 
 mRNA for calmodulin, complete cds 3.45 ↑ D45887 
 insulin-like growth factor mRNA, complete cds 4.78 ↑ M27544 
 mRNA for beta-actin 7.69 ↑ X00351 
    
Cell metabolism ureidopropionase, beta (UPB1), mRNA 3.46 ↓ NM_016327 
 protein kinase, AMP-activated, gamma 2 non-catalytic  subunit (PRKAG2), mRNA 2.40 ↓ NM_016203 
 cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 18 2.12 ↓ M61856 
    
Cytoskeleton zyxin (ZYX), transcript variant 1, mRNA 44.72 ↑ NM_003461 
 villin 1 (VIL1), mRNA 4.06 ↓ NM_007127 
 mRNA fragment for mesothelial type II keratin K7 2.18 ↓ X03212 
 mRNA for cytokeratin 4 C-terminal region 2.09 ↓ X07695 
 cytokeratin 2 mRNA, complete cds 2.05 ↓ M99063 
    
Signal 
transduction  doublecortin and CaM kinase-like 1 (DCAMKL1), mRNA 4.59 ↓ NM_004734 
 
protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1, 
mRNA 16.53 ↑ NM_002730 
 GRB2 isoform mRNA 3.59 ↓ L29511 
 Ras protein-specific guanine nucleotide-releasing factor 1 4.68 ↑ L26584 
 G protein-coupled receptor (GPR2) gene, partial cds 10.39 ↑ U13667 
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 mRNA for phospholipase C 10.64 ↑ X14034 
    
Genes involved in 
protein trafficking  transient receptor potential cation channel, subfamily V, member 2 (TRPV2), mRNA 2.07 ↓ NM_015930 
 RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae) (RER1), mRNA 2.01 ↓ NM_007033 
 nucleoporin 214kDa (NUP214), mRNA 2.07 ↑ NM_005085 
 potassium channel, subfamily K, member 9 (KCNK9), mRNA 2.15 ↑ NM_016601 
 coatomer protein complex, subunit epsilon (COPE), transcript variant 1, mRNA 2.27 ↑ NM_007263 
  ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D), mRNA 2.38 ↑ NM_015994 
 vacuolar protein sorting 4A (yeast) (VPS4A), mRNA 3.32 ↑ NM_013245 
 cardiac tetrodotoxin-insensitive voltage-dependent  
 sodium channel alpha subunit (HH1) mRNA, complete cds 
2.39 ↑ M77235 
 mRNA for Icln protein 5.07 ↑ X91788 
 glycine transporter type 1b  2.70 ↑ S70609 
    
Translational 
factors  LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) (LSM7), mRNA 2.55 ↓ NM_016199 
and regulation heterogeneous nuclear ribonucleoprotein H1 (H) (HNRPH1), mRNA 2.07 ↑ NM_005520 
 RNA binding motif protein, X-linked 2 (RBMX2), mRNA 3.05 ↑ NM_016024 
    
Transcriptional 
factors  zinc finger protein 84 (HPF2) (ZNF84), mRNA 2.58 ↑ NM_003428 
and regulators zinc finger protein 45 (ZNF45), mRNA 3.03 ↑ NM_003425 
 zinc finger protein 74 (Cos52) (ZNF74), mRNA. 5.29 ↑ NM_003426 
 zinc finger protein 157 (HZF22) (ZNF157), mRNA 10.41 ↑ NM_003446 
 zinc finger protein 91 (HPF7, HTF10) (ZNF91), mRNA 46.05 ↑ NM_003430 
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 TBP-like 1 (TBPL1), mRNA 6.05 ↓ NM_004865  
    
Hypothetical 
proteins zinc finger protein 226 (ZNF226), transcript variant 4, mRNA 2.18 ↓ NM_015919 
 protease, serine, 15 (PRSS15), nuclear gene encoding mitochondrial protein, mRNA 2.02 ↓ NM_004793 
 CCR4 carbon catabolite repression 4-like (S. cerevisiae) (CCRN4L), mRNA 2.33 ↑ NM_012118 
 transcription factor LCR-F1 mRNA, complete cds 2.07 ↑ U08853 
 cyclin K (CPR4) mRNA, complete cds 2.34 ↑ AF060515 
 R kappa B mRNA, complete cds 2.77 ↑ U08191 
 I-Rel mRNA, complete cds 3.12 ↑ M83221 
 telomerase reverse transcriptase (hTRT) mRNA, complete cds 4.08 ↑ AF015950 
 mRNA for DB1, complete cds 8.47 ↑ D28118 
 B-cell specific transcription factor (BSAP) mRNA, complete cds 9.19 ↑ M96944 
 cylindromatosis (turban tumor syndrome) (CYLD), mRNA 3.27 ↓ NM_016385 
 archaemetzincins-2 (AMZ2), transcript variant 1, mRNA 2.78 ↓ NM_016627 
 thioredoxin domain containing 12 (endoplasmic reticulum) (TXNDC12), mRNA 2.46 ↑ NM_015913 
    
Cell receptors scavenger receptor class A, member 3 (SCARA3), transcript variant 1, mRNA 2.14 ↑ NM_016240 
 major histocompatibility complex, class I, A (HLA-A),  mRNA 2.40 ↑ NM_002116 
 interleukin 8 receptor, beta (IL8RB), mRNA 12.44 ↑ NM_001557 
 Prohibitin 3.68 ↓ S85655 
 
(clones BT3.081.8, BT3.129.5 and BT4.169) receptor tyrosine kinase (KDR) mRNA, 
3' end cds 2.06 ↓ L04947 
    
Additional genes syndecan binding protein (syntenin) (SDCBP), transcript variant 1, mRNA 221.40 ↑ NM_005625 
 dynein, axonemal, light intermediate polypeptide 1            (DNALI1), mRNA 2.45 ↑ NM_003462 
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 antizyme inhibitor 1 (AZIN1), transcript variant 1, mRNA 4.51 ↓ NM_015878 
 metallothionein 1L (MT1L), mRNA 3.48 ↓ NM_002450 
 CBF1 interacting corepressor (CIR), transcript variant 1, mRNA 3.22 ↓ NM_004882 
 REV1-like (yeast) (REV1L), mRNA 2.43 ↓ NM_016316 
 Down syndrome critical region gene 1-like 1 (DSCR1L1), mRNA 2.07 ↓ NM_005822 
 pregnancy specific beta-1-glycoprotein 4 (PSG4), transcript variant 1, mRNA 2.01 ↓ NM_002780 
 cytochrome b5 reductase 2 (CYB5R2), transcript variant 1, mRNA 2.06 ↑ NM_016229 
 JTV1 gene (JTV1), mRNA 2.36 ↑ NM_006303 
 cytochrome b5 reductase 1 (CYB5R1), mRNA 2.53 ↑ NM_016243 
 CGI-77 protein (CGI-77), mRNA 3.22 ↑ NM_016023 
 hydroxyacid oxidase 3 (medium-chain) (HAO3), mRNA 4.02 ↑ NM_016528  
chromosome 1 open reading frame 9 (C1orf9), transcript variant 2, mRNA 7.58 ↑ NM_016227 
 cartilage paired-class homeoprotein 1 (CART1), mRNA 13.85 ↑ NM_006982 
 guanine nucleotide regulatory protein (NET1) mRNA, complete cds 2.67 ↓ U02081 
 5T4 gene for 5T4 oncofoetal antigen 2.52 ↓ Z29083 
 CD9 antigen mRNA, complete cds 2.43 ↓ M38690 
 glutamate decarboxylase (GAD65) mRNA, complete cds 2.33 ↓ M81882 
 CD53 glycoprotein mRNA 2.20 ↓ M37033 
 proneurotensin/proneuromedin N mRNA, complete cds 2.09 ↓ U91618 
 mRNA for dihydrolipoamide acetyltransferase (PDC-E2)  2.07 ↓ Y00978 
 mRNA for MEGF6 protein (KIAA0815), partial cds 2.24 ↑ AB011539 
 MTCP1 gene, exons 2A to 7  2.31 ↑ Z24459 
 neuroendocrine-dlg (NE-dlg) mRNA, complete cds 3.13 ↑ U49089 
 Homo sapiens zona pellucida glycoprotein 2 (sperm receptor) (ZP2), mRNA 2.33 ↑ NM_003460  
    
 
  
5.1  Utilizing real time RT-PCR to confirm modified transcription of  
specific genes 
Although the microarray results yielded exciting results which suggested genes 
that were either transcriptionally upregulated or downregulated following transfection 
with SARS CoV Spike, real time RT-PCR was performed on 5 interesting genes whose 
expression levels were generally upregulated (Table 7). Relative expression levels 
between the Spike construct transfection and plasmid control were compared and 
subjected to one-way nonparametric ANOVA followed by Tukey’s T test which is a 





























Table 6.  Real Time PCR analysis comparing transfection of HLCZ cells with 
control plasmid pCDNA3.1 vs pCon-Harv-S-Myc-His and their relative 
expression to the conserved gene HUEL.  
 
ANOVA & Tukey's Multiple 
Comparison Test  Mean Diff. q P value 95% CI of diff 
  SLC20 T vs SLC20 U -0.5467 2.857 P > 0.05 -1.505 to 0.4116
  RBlike T vs RBlike U -1.033 5.401 P < 0.05 -1.992 to -0.07510
  MHCC1a T vs MHCC1aU 0.06 0.3136 P > 0.05 -0.8982 to 1.018
  IL8 T vs IL8 U -1.427 7.456 P < 0.01 -2.385 to -0.4684
  Actin T vs Actin U -1.177 6.15 P < 0.01 -2.135 to -0.2184
 
Table 6a.  ANOVA and variance of Students T test comparing the significance of 
changes in values for each group of the 5 genes of interest between 
controls and transfected HLCZ.  p<0.001 is significant. 
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Gene name GenBank 
 Accession # 




Major histocompatibility complex, 








































Carrier family 20 (phosphate 












Table 7  Characteristics of 5 gene of interests displaying altered transcription 
profiles following transfection by pCon-Harv-S Myc-His  
 
The levels of gene transcriptions of the 5 genes involved in the Spike transfected 
and pCDNA3.1 transfected HLCZ cells were monitored with Real Time PCR and 
represented by CT values (Table 8). The Real Time PCR reactions were repeated 3 times 
and in triplicates per run.  For each GOI, a comparison of the CT values was compared 
against the average of the CT value of the house keeping gene HUEL in both the Spike 
transfected and pCDNA3.1 transfected reactions and the difference between the values 
suggested either and increase or decrease in the regulation of the gene represented by 
∆CT. Further calculations and relative expression of the genes were then generated as 
∆∆CT values as the GOI were expressed as a value relative to HUEL. Table 7 represents 
these values of expression levels of the 5 GOIs relative to HUEL. The house keeping 
gene, HUEL, showed a constant CT value in both the Spike transfected and pCDNA3.1 
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transfected samples and allowed us to use HUEL as the normalization control. With the 
HUEL gene serving as a normalization control, the changes in expression at 24 hr post 
transfection and the p values from Tukey’s comparison test is listed in table 7 and 7a. 
Results from real-time RT-PCR for the transcript encoding Major histocompatibility 
complex, class I, concured with the microarray data whilst the other genes did not.  Based 
on the previous study using live SARS viral infection of Vero E6 cells, the expression 
profile of an additional gene absent from the microarray (Carrier family 20 (phosphate 
transporter), member1 (SLC20A1) was also elucidated by real-time RT-PCR. This gene 
however showed 1.5-fold change. In this study, the gene expression patterns 
demonstrated by real time RT-PCR were different from the data generated by microarray 
studies. The disparity between results obtained from the 2 methods could be attributed to 
the different dynamics and the kinetics of gene detection. As shown, relative changes in 
expression levels of the 5 GOIs were more subtle by real time RT-PCR. Nevertheless, 
both realtime RT-PCR which is based on actual upregulation of target genes as compared 
to microarray which based its detection value and threshold of fluorescent intensities 
emitted from the hybridized fluorophore are tools that can be employed to study gene 
expression profiles. A further more indepth study with other transcripts highlighted in this 
section using realtime RT-PCR has to be performed to determine the reliability and 
representation of gene regulation in response to transfection with the Spike construct. 
Interestingly though, levels of interleukin 8 receptor beta was found to be 
decreased by 0.2- fold in the RT-PCR analyses in our study which contrast the finding of 
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  HUEL   SLC20               
Spike-trans 22.29 22.28 22.22 19.79 19.76 19.76 22.26 -2.47 -2.50 -2.50 -2.49 0.0 0.0 0.0 1.0 1.0 1.0 1.0 0.012 






0.5 1.5 1.5 1.4 1.5 0.041 
                    
  HUEL   RBlike               
Spike-trans 22.3 22.3 22.2 23.93 23.73 23.85 22.26 1.67 1.47 1.59 1.57 0.1 
-
0.1 0.0 0.9 1.1 1.0 1.0 0.07 




0.1 1.0 1.1 1.1 1.0 0.043 
                    
  HUEL   MHCC1a               
Spike-trans 22.3 22.3 22.2 28.11 28.17 27.71 22.26 5.85 5.91 5.45 5.73 0.1 0.2 
-
0.3 0.9 0.9 1.2 1.0 0.182 






2.0 1.3 2.1 4.1 2.5 1.419 
                    
  HUEL   IL8               




0.1 0.8 1.2 1.1 1.0 0.237 
pCDNA3.1 trans 23.6 23.2 23.3 34.59 34.14 33.83 23.36 11.23 10.78 10.47 10.50 0.7 0.3 0.0 0.6 0.8 1.0 0.8 0.208 
                    
  HUEL   Actin               
Spike-trans 22.3 22.3 22.2 17.69 17.65 17.87 22.26 -4.57 -4.61 -4.39 -4.53 0.0 
-
0.1 0.1 1.0 1.1 0.9 1.0 0.08 
pCDNA3.1 trans 23.6 23.2 23.3 19.13 18.95 18.66 23.36 -4.23 -4.41 -4.70 -4.53 0.3 0.1 
-
0.2 0.8 0.9 1.1 0.9 0.158 
                    
  HUEL   HUEL               
Spike-trans 22.29 22.28 22.22 22.29 22.28 22.22 22.26 0.03 0.02 -0.04 0.00 0.0 0.0 0.0 1.0 1.0 1.0 1.0 0.026 




0.1 0.9 1.1 1.0 1.0 0.116 
Table 8:  CT values of transfected cells vs untransfected cells generated by real time RT-PCR and the calculation of relative  
expression normalized to CT of HUEL
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6.0 DISCUSSIONS 
The outbreak of severe acute respiratory syndrome (SARS) worldwide in 
November 2002 resulted in thousands of people who were infected and 774 fatalities, 
mostly in Asia (He et al, 2004; Zhou et al, 2004; Chad, et al, 2004; Chang, et al, 2004; 
Dong et al, 2004; WHO, 2003). Infection is characterized by acute flu-like symptoms, 
causing atypical pneumonia with diffuse alveolar damage (Yang et al, 2004; Jeffers et al, 
2004). Intensive collaborations and cooperation between health and research teams 
worldwide soon identified a deadly novel coronavirus as the etiological agent of this 
atypical disease (Rota et al, 2003; Holmes et al, 2004; Drosten et al, 2003; Han et al, 
2004; He et al, 2004). This global outbreak of SARS had devastating effects on public 
health and socioeconomic stability worldwide and threatened livestock, poultry and 
laboratory rodents. (Jiang, et al, 2003; Holmes, 2003) By 2003, the outbreak was finally 
put under control. However, several isolated cases of accidental releases of SARS-CoV 
from laboratories subsequently occurred in Taiwan, Singapore and China 
(http://www.who.int/csr/sars/en). This suggests the possible re-emergence of this deadly 
virus in future and is therefore highly imperative that an effective and safe vaccine is 
developed to prevent and control the new SARS epidemic (He et al 2004; Holmes, 2003). 
Although there are 3 groups of Coronavirus and SARS-CoV is a new member of the 
genus Coronavirus, it does not belong to any of the groups (Jiang et al 2003). Studies 
have shown that SARS-CoV resembled the group 2 coronavirus which include bovine 
coronavirus, murine hepatitis virus and human coronavirus OC34 (HcoV-OC43) (Snijder, 
et al 2003; Guan et al, 2003; Holmes et al, 2003). Interestingly, other strains of human 
coronaviral infections cause only mild upper respiratory inflammation but do not cause as 
extensive and severe clinical symptoms as that by this novel human CoV. The exact 
origin of this SARS-CoV is still relatively unknown and its infection mechanism and viral 
99 
mutational capability remains to be fully elucidated. The first evidence that SARS-CoV 
may have originated in animals was when a SARS-CoV-like virus with high homology to 
human SARS-CoV was identified in palm civets and other animals in Guangdong (Jiang 
et al 2003; Guan et al, 2003 suggesting that the virus was able to recombined with the 
human strain and under selective pressure in humans, evolved to form the late SARS-
CoV which caused global outbreaks with high death rates.  (Holmes, 2003; Edward et al, 
1982) Examples of animal viruses crossing the species barrier to humans already exist, 
e.g. Nipah virus (pigs) and H5N1 influenza virus (avian). 
 
Characterization of the putative 3A protein 
The novel strain of SARS-CoV contained other putative proteins encoded by open 
reading frames which were not found in other coronavirus such as the 3A protein (Marra 
et al, 2003; Rota et al 2003; Thiel et al). Optimization of the ratio of Transfectin to 
pCMV-3A plasmid construct was required for the successful uptake in Vero E6 cells. 
Following 24 hour of transfection with the 3A construct, however, expression of the 
pCMV-3A was not detected in Vero E6 cells. No visible bands were detected using anti-
cMyc antibodies (Data not shown). This fully concurred with previous studies that 
showed only infected-transfected mammalian cells with the constructs were able to 
express 3a (Yu et al., 2004). This suggests that protein 3a was selectively expressed in 
SARS-CoV- infected cells (Yu et al., 2004). Preliminary transfection of 3A constructs of 
Baby Hamster Kidney (BHK) cells seemed to suggest small amounts of apoptosis. 
However, recent studies demonstrated that overexpression of 3A in cell lines was unable 
to induce apoptosis and have been postulated to be a minor structural protein in 
correlation with M, N, E and S proteins (Tan et al., 2004; Yu et al., 2004). The presence 
of SARS-CoV protein3a could be detected in infected Vero E6 cells at 8 to 12 hours post 
100 
infections and also in the pneumocytes of a SARS patient’s lung (Yu et al., 2004). 
Immunofluorescence staining of the protein 3a showed the distribution of 3a in a 
punctuate pattern with partly concentration in Golgi apparatus. It was hypothesized that 
during virus evolution, protein 3a was positively selected together with the spike protein 
(Yeh et al., 2004), suggesting that the high frequency mutations or evolution adaptive 
property of protein is important in the virus life cycle and disease development (Yu et al., 
2004)  
In recent studies, the protein 3a was found to be tightly correlated to the spike 
protein and associated with cytoplasmic membrane in infected cells (Zeng et al, 2004; Ito 
et al, 2004) and is thought to be a minor structural protein on the surface of SARS-CoV 
viral envelop. In order to understand the infection mechanism of SARS-CoV with an 
emphasis identifying a broad spectrum of novel receptors and interactions involved when 
a mammalian cell is infected by SARS-CoV, we cloned the 3A gene into a yeast shuttle 
vector containing the GAL4 DNA binding domain (DNA-BD) which replicates 
autonomously in both E. coli and S. cerevisiae to create the “bait” to be employed in 
Yeast Two Hybrid to identify and locate receptors that will interact with SARS CoV 3A 
gene. However, we were unable to obtain a functional “prey” containing the human 
cDNA library from our supplier and could not proceed with the assay. Recent studies 
have demonstrated that the protein 3A up-regulates the expression of fibrinogen in lung 
epithelial cells (Tan et al, 2005). This finding concurs with clinical observations of 
patients infected with SARS-CoV had thrombocytopenia (Lee et al, 2003; Pieris et al, 
2003) which suggest a dysfunctional  coagulation and activation of the fibrinogen 
pathway. It would be interesting to study the effect of SARS CoV 3A on the 
transcriptome of cells using microarray and to identify various interacting proteins by 
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using yeast 2 hybrid to aid in our understanding of viral infection mechanisms and the 
roles these proteins play in pathogenesis.  
 
Transciptome analysis of   SARS-CoV Spike transfection  
Extensive studies have been carried out involving the characterization and the 
function of the SARS-CoV Spike glycoprotein. Being the first protein to interact with the 
cell surface membrane which leads to a cascade of infection events in a cell, the Spike 
protein is possibly the most important viral protein as a target for antiviral drugs . Studies 
have classified the Spike protein to be a type 1 transmembrane glycoprotein which is 
responsible for virus binding, fusion and entry (Peiris et al, 2003; Holmes, 2003). The 
spike protein has been sequenced and found to contain 3 domains; an extracellular 
domain, a transmembrane domain and an intracellular domain. (Jiang et al, 2004; He et 
al, 2004). Of particular interest and importance is the S1 unit which is one of the 2 
subunits of the extracellular domain (Holmes, 2003). This domain is responsible for the 
virus to bind to the receptor, angiotensin-converting enzyme 2 (ACE2) (Li et al, 2003; 
Prabakaran et al 2003; Dimitrov, 2003) present on susceptible cells. 
In order to understand the pathophysiology and role of the Spike protein in SARS-
CoV infection and the host celllar responses, we employed transfection methods, cDNA 
microarray and RT-PCR to investigate gene expression changes during the transfection 
process using a SARS CoV Spike construct.  Previous studies in our lab as well as other 
groups have demonstrated that Vero E6 are the most permissive for SARS-CoV infection 
and replication (Drosten et al., 2003; Ksaizek et al., 2003; Peiris et al., 2003; Leong et 
al.,2005). Vero E6 cells are derived from the African green monkey (Cercopithecus 
aethiops) kidney clone E6 and have been used widely as a model for studies of viral 
infections in mammalian cells. However, as it is not a human cell line, there could be 
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some limitations during cross hybridization of probes during microarray or the 
observation of different pathological effects when the cells are transfected with SARS-
CoV. Based on previous evolutionary studies and divergence, the human closest relative 
is the chimpanzee, followed by the gorilla, orangutan and Old World monkeys (macaque 
and African green monkey) (Kelley et al., 1992; Shi et al., 2003).  There has been no 
human cell lines that were susceptible to SARS CoV infection with the exception of 
LoVo cells (Chan et al., 2004) and recently Hep G2 and Huh-7, both of which are liver 
hepatocellular carcinoma cells (Kaye et al, 2004; Tan et al, 2004). Studies have 
demonstrated that persistent infection in LoVo cells did not exhibit visible cytopathic 
effect (CPE) which contrasts the lytic infection seen in Vero E6 cells (Leong et al., 2005). 
This mimcs the apoptosis observed in the respiratory epithelial cells of severly ill SARS 
patient (Lang et al., 2003; Tse et al., 2004; Yang et al., 2004; Leong et al., 2005). 
However, in this study, we were able to transfect a human cell line, HL-CZ, with our 
CoV-spike constructs. HL-CZ is a human promonocytic leukemia lymphoblast 
established from an adult Chinese male T cell leukemia. Infection by viruses in these cells 
would trigger a cascade of immunological response. The effect of transfection with our 
spike constructs would reveal a wide repertoire of cell signaling and trafficking genes that 
would be involved in the host response to SARS CoV Spike and shed light on its specific 
role during viral infection. 
 
Microarray analysis of the changes in levels of gene expression 
  From our microarray analysis, 102 genes were identified with altered expression 
levels and were classified according to their functional roles in the cell response to 
transfection. The most distinguishable genes to be downregulated by the transfection were 
those involved in cell metabolism and cytoskeleton while genes that were involved in 
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protein trafficking were generally upregulated. For transcripts that encode cell cycle 
proteins, the microarray data suggests a mixed response in the host cell. 
SARS CoV infected cells exhibited diminished expression of genes related to the 
maintenance of cytoskeletal structure. Many cellular processes depend on cytoskeletal 
rearragements. Villin 1 is a structural protein regulated by increased intracellular calcium 
that in turn binds to actin and contributes to the formation of microvilli in the small bowel 
(Pinson et al., 1998). It is also expressed in intestinal metaplasia observed in Barett’s 
esophagus and in chronic atrophic gastritis and is an important marker of the pre-
neoplastic cell type that forms in the gut in response to chronic injury (Regalado et al., 
1998). Mesothelial and cytokeratins are part of the family of keratins that contain about 
20 different proteins that comprises intermediate filaments in almost all epithelial cells. 
These filaments form the internal “infrastructure” of cells and are vital for the cell to 
maintain cellular integrity. Disruption of such features would affect cellular flexibility, 
tensile strength and the ability to interact with other cellular components (Glass et al., 
1985). Infection of animal cells by a number of viruses generally results in CPE. In 
adenoviral infections, there is a profound loss of cell structural integrity and inhibition of 
host protein synthesis which was related to widespread destruction of the intermediate 
filament network, particularly proteolysis of cytokeratins K7 and K18 by the adenovirus 
late-acting L3 proteinase  (Zhang et al., 1994). The collapse of the intermediate filament 
network including vimentim and lamin networks coupled with the inhibition of protein 
synthesis of new keratin to restore the damaged filament network contributes to CPE by 
the impairment of structural integrity of the cells. In SARS CoV infection, these 
microtubule networks may have become disrupted upon binding of the Spike protein to 
the receptor on the cell prior to entry of the virus, hence, making it conducive for 
persistent viral infection and subsequent release.  
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Besides microtubles and cytokeratin, genes that are directly or indirectly involved 
in actin assembly are also greatly affected during the SARS CoV Spike transfection. In 
our observation, the mRNA encoding zyxin was greatly upregulated. Zyxin is a protein 
that has been postulated to play an important role in the regulation of the actin 
cytoskeleton particularly in the inner face of the plasma membrane of cells (Drees et. 
al.,1999. Mislocation of zyxin would affect cell migration and spreading, and affects the 
behavior of the cell edge. Correct positioning of zyxin within the cell is also critical for its 
physiological function, as studies have demonstrated that mislocation of zyxin will cause 
the irregular distribution important proteins that promotes actin assembly (Drees et al., 
1999).Although the precise mechanism by which zyxin enhances cell motility through the 
rearrangement of actin is not fully known, it was suggested that zyxin functions to 
facilitate the formation of molecular complex that promotes site-specific actin assembly, 
particularly to promote the assembly of actin-rich structures when targeted to the plasma 
membrane (Beckerle, 1997; Golsteyn et al., 1997). In our transfection of SARS CoV- 
Spike, the expression of the Spike protein at the plasma membrane could have triggered 
the upregulation of the gene encoding zyxin to synthesize more zyxin protein so as to 
promote more actin assembly at the site where the Spike protein is expressed. At the same 
time, the cell is trying to cope with the sudden degradation of villin and the disruption of 
cytokeratins and other cytoskeletal proteins during the mock infection by the Spike 
construct and abruptly upregulates the gene encoding zyxin to help in the restoration of 
structural integrity. This was further supported by the microarray data which 
demonstrated the upregulation of the transcript for beta-actin by 7.69 fold, suggesting that 
the cells were greatly in need for the beta actin protein to be formed and in large amounts 
to be sequestered to restore structural order within the cell.  
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The disruption of intracellular cytoskeleton framework following SARS CoV 
Spike transfection in HLCZ cells was also accompanied by the a mixed response in 
regulation of transcripts that encode cell cycle proteins suggesting an interesting interplay 
of gene regulation by the host in response to the expression of viral spike protein. 
Prothymosin alpha is an abundant mammalian acidic nuclear protein (Gomez-Marquez et 
al., 1998) and its function has been postulated to support cell proliferation (Sburlati et al., 
1991). This protein is present in all mammalian tissues and is usually proportional to the 
proliferative activity of the tissue. Although prothymosin alpha does not directly regulate 
cell division, it is required by the cell to enter from the G2 phase to the M phase in the cell 
cycle and its transcript, prothymosin alpha mRNA, has been shown to be induced in 
normal human lymphocytes when stimulated by mitogens (Sburlati et al.,1991). From our 
microarray analysis, prothymosin alpha transcript was upregulated by 6.37 fold, 
suggesting that the transfection of Spike construct into HLCZ cells induced the 
upregulation of prothymosin alpha. This is supported by extensive viral infection studies 
which have established that viral infections transmits proliferation signals to otherwise 
terminally differentiated cells (Vaerli et al., 1995; Young et al 1989) . Studies have also 
indicated that cells that overexpress this transcript have higher levels of histone-H1 
depleted chromatin and hence, has a biological role in the remodeling of chromatin fibres 
by interacting with histone H1 which leads to the decondensing the chromatin fibres 
(Sburlati et al., 1991). We observe the same trend in our microarray analysis which 
demonstrates an upregulation of the histone 1 transcript in concurrent fashion with that of 
prothymosin. Such changes in levels of chromatin organization are important as they are 
required for essential cellular processes, such as recombination, replication, transcription 
and chromosome packaging.   
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Another transcript that was upregulated which is of importance is histone 
deacetylase 5 (HDAC-5). The protein encoded by this transcript also plays an important 
role in chromatin remodeling. Whether a cell is permissive for viral infections could be 
dependent on the state of cellular differentiation. In particular, the permissiveness for 
human cytomegalovirus (HCMV) infection is linked to the repression of the viral major 
immediate early promoter (MIEP) (Murphy et. al., 2002). In HCMV, monocytes are 
believed to be a site of viral latency in HCMV carriers and reactivated virus is only 
observed upon differentiation into macrophages. Conversely, histone deacetylases are 
involved in repression of the MIEP in non-permissive cells as inhibition of the HDACs 
induces viral permissiveness and increases MIEP activity (Murphy et al., 2002). The 
HDACs act to modulate the transcriptional activity of MIEP by affecting the acetylation 
of transcriptional factors as well as histones. Hence, in nonpermissive cells, with more 
histone deacetylase, MIEP would be repressed and the cell would not be very permissible 
to viral infections. Our microarray data shows a modest 2.18 fold upregulation of the 
transcript, suggesting that the HLCZ cells were only slightly permissive to the 
transfection of Spike constructs. This is expected and our transfection model is able to 
demonstrated strong expression of the spike construct in our western blot analyses and 
immunofluorescent imaging. However, most of the SARS CoV infection studies have 
been using Vero E6 cells, which have been shown to exhibit massive CPE, hence 
suggesting that Vero E6 cells are more permissive than HLCZ cells. A recent study shows 
that histone deacetylase 6 regulates the formation of HIV-mediated fusion pore and thus 
viral infection (Angeles et al., 2005). It was suggested that the binding of the HIV viral 
gp120 protein to CD4+- permissive cells increased the level of acetylated α-tubulin and 
conversely,  overexpression of active HDAC6 would inhibit the acetylation of the tubulin 
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and hence, prevent HIV-1 envelope dependent cell fusion as well as infection without 
affecting the expression of other HIV-1 receptors (Angeles et al., 2005).   
In our microarray data, we observed an increased expression in the transcript for 
cyclin A1. The protein encoded by the transcript, cyclin A1, binds to and regulates cdk2 
and cdk1, which are important factors for cell cycle during the S and G2 phases, which 
are important for viral life cycle. As such, regulation of cyclin A1 mRNA has an indirect 
impact on the maturation of viruses. In HIV-1 progeny formation, cyclin A1 has been 
shown to bind Rb family members, the p21/waf1 family of endogenous cdk inhibitors, as 
well as the E2F-1 transcriptional factor, all of which are important in the regulation of cell 
cycle progression (Liang et. al., 2005). Furthermore, cyclin A1 plays an important role in 
DNA double-strand break repair following radiation damage by activation of non-
homologous end-joining process that confers DNA stability (Muller-Tidow et al 2004). 
Hypermethylation of cyclin A1 promoter has been found to be expressed in invasive 
human papillomavirus associated cervical cancer. Following transfection with the Spike 
construct, the gene for cyclin A1 is upregulated by 3.95 fold, possibly to signal the host 
cell to undergo cell division by allowing the cell to enter the meiosis phases causing a 
disruption to the regular cell division cycle and coercing the host cells to mature quickly. 
Another gene transcript that is noteworthy is the regulation of ICln mRNA. This 
encodes a 42kDa chloride channel regulatory protein, ICln, which is essential in 
regulating cell volume and interacts highly with the specific platelet integrin αIIbβ3 
through the KVGFFKR motif platelet membranes (Larkin et. al., 2004). It is found in the 
cytosol in cells at rest, but is associated with the cell membrane following a hypotonic 
challenge. When challenged with the specific channel protein inhibitory agent, acyclovir, 
inhibition of platelet aggregation and integrin activation was observed, suggesting the role 
for ICln chloride channel in platelet aggregation. The transfection of SARS Spike 
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construct into HLCZ cells could have caused a sudden increase in intracellular solute 
content, forcing the cells to counteract swelling by activation of chloride and potassium 
channels, thereby upregulating the gene ICln sharply (5.07 fold increase), which then lead 
to a net efflux of salt followed by water, until returning to isotonic conditions.  
In this study, the vacuolar protein sorting 4A gene transcript was upregulated 
slightly.  In retroviral infections, the viral protein must recruit a variety of host cellular 
factors including members of the vacuolar protein sorting family to escape the cell, 
otherwise, the viral particles woul be nearly assembled but remain tethrered to the cell 
surface (Carter et. al., 2002; Pornillos et. al., 2002; Sherer et. al., 2003). This suggests 
that 24 hrs post transfection with the Spike construct which mimics a viral infection, the 
construct is able to interact with the vacuolar protein sorting machinery in the 
multivesicular bodies (MVBs) in HLCZ cells which could lead to subsequent budding 
and viral egress. 
In our transfection studies, most of the transcriptional factors that were up-
regulated were zinc finger proteins. These small subunits of larger proteins have been 
demonstrated to bind directly to viral mRNA (Dvorak et al, 2001; Guo et al, 2004). The 
exact functions of these zinc finger motifs and their interacting relationship with the gene 
targets have yet to be elucidated which may further our understanding of the cellular 
response to SARS-CoV infection.    
Patients who were infected by SARS-CoV showed high plasma levels of IL-1, IL-
6, IL-8, IL-12, monocyte chemoattractant protein-1 and IFN-γ inducible protein 
(Openshaw, 2004). High serum levels of IL-8 and IL-6 in the acute stage associated with 
lung lesions were found in SARS patients and the elevations of the plasma chemokine IL-
8 and Th1-related cytokine induces hyperinnate inflammatory response due to the SARS-
CoV invasion of the respiratory tract. A recent study that was carried out using 
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recombinant baculovirus expressing the aa 17-688 fragment of the S-protein 
demonstrated the Spike proteine induces AP-1 activation through the MAPKs and AP-1 
and that region aa 609-688 was critical for the induction of IL-8 release in lung cells 
(Chang et. al., 2004) (See Fig. 14). The study also demonstrated that the induction of IL-8 
was specifically inhibited by the angiotensin-converting enzyme 2 Ab (ACE2). Our 
microarray study corroborates with another study that demonstrated the upregulation of 
IL8RA (which is a low affinity receptor for IL-8) when Vero E6 cells were infected with 
SARS-CoV (Leong et al, 2005; Chuntharapai et al, 1995). The sharp upregulation of IL-8 
receptor transcript β (which has a stronger affinity for IL-8) in our studies confirms that 
the host cells have been successfully “infected” with the Spike construct and is actively 
upregulating the IL-8 receptor β transcript as an inflammatory response. This 
overproduction of specific inflammatory cytokines and IL-8 are the hallmarks of viral 






















Fig. 14.  Schematic diagram of signaling pathways involed during Spike 
glycoprotein mediated IL-8 regulation pathway upon SARS-CoV 
infection of lung cells. S protein acts through ACE2 receptor or 
unknown coreceptor(s) to activate ERK1/2, p38, or JNK, leading to 
the activation of AP-1 on the IL-8 promoter, and initiation of IL-8 
mRNA expression and protein release. Two functional domains aa324-
488 and 609-688 are essential for the induction of IL-8 release (Chang 






B cells are developed from stem cells in the bone marrow and can develop 
antigen-specific surface antibody. They have surface receptors which enable them to 
recognize appropriate antigens. Upon recognition of the antigens, the B cells migrate to 
the secondary lymphoid tissues and proliferate to form lymphocytes and plasma cells 
which produces antibodies to neutralize the antigens. Some of the activated B cells turn 
into memory cells and provides small basal amounts of circulating antibodies. In HIV 
infections, the virus requires the activation of a protein called DC-SIGN which is a 
molecule on the surface of B cells to be able to successfully infect T cells. Our microarray 
data shows that upon transfection of the Spike construct in HLCZ, the transcript for B-
cell is increased 9.19 fold, suggesting that the B cells is able to recognize the expressed 
Spike construct and is actively attempting to produce more B cells in an attempt to 
counter the “infection”.   
 
The 5 genes of interest 
 Real time RT-PCR was employed to verify the microarray analysis of 5 selected 
genes, Homo sapiens solute carrier organic anion transporter family, member 1A2 
(SLCO1A2), transcript variant 3, major histocompatibility complex, class I, A, Homo 
sapiens retinoblastoma-like 1 (p107) (RBL1), transcript variant 1, Homo sapiens 
interleukin 8 receptor, beta (IL8RB) and beta actin. The gene Homo sapiens solute 
carrier organic anion transporter family, member 1A2 (SLCO1A2), transcript variant 3 
encodes for part of a receptor which allows infection of human and murine cells by 
various retroviruses. Currently, only certain retroviral receptors have been identified at 
the molecular level. This include CD4 (MIM 186940) for human immunodeficiency 
virus, Rec1 for murine ecotropic virus, and GLVR1 for gibbon ape leukemia virus. These 
3 proteins show no homology to one another at the DNA or protein level. GLVR1 is a 
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sodium-dependent phosphate symporter. Our Real Time RT-PCR data showed a 1.5- fold 
increase in gene expression when transfected with pCon-S-Myc-His construct compared 
to mock transfected pcDNA3.1 control suggesting that during transfection, the Spike 
protein have caused the HLCZ cells to up-regulate the receptor gene.  
 The other gene that is up-regulated is the major histocompatibility complex 
class I A. HLA-A belongs to the HLA class I heavy chain paralogues. This class I 
molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 
microglobulin). The heavy chain is anchored in the membrane. MHC Class I molecules 
play a central role in the immune system by presenting peptides derived from the 
endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is 
approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, 
exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 
encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 
encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for 
the peptide binding specificity of each class one molecule. Typing for these 
polymorphisms is routinely done for bone marrow and kidney transplantation. Real Time 
RT-PCR data showed that this gene is the most up-regulated (2.4- fold increase in gene 
expression compared to controls) among the 5 genes being investigated. As HLCZ cells 
are monocytic leukemia cell lines derived from adult T cells, where MHC class 1 are 
typically expressed, up-regulation of this gene was expected. This is in agreement with 
the microarray analyses.  
 However, the other 3 genes showed little or no change in levels of gene 
expression based on Real Time RT-PCR results. However, our microarray data showed 
otherwise. Surprisingly, our real time PCR results showed no change in IL-8RB receptor 
gene expression levels while microarray data showed a strong upregulation of 12.44- fold 
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increase in gene expression.  The IL-8 receptor is a member of the G-protein-coupled 
receptor family and is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, 
and transduces the signal through a G-protein activated second messenger system. The 
receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with 
melanoma growth stimulating activity, and has been shown to be a major component 
required for serum-dependent melanoma cell growth. The IL-8 receptor mediates 
neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal 
microvascular endothelial cells are found to be mediated by this receptor. Knockout 
studies in mice suggested that this receptor controls the positioning of oligodendrocyte 
precursors in developing spinal cord by arresting their migration 
(www.ncbi.nlm.nih.gov). Recently, another gene, IL-8 receptor A (IL8RA), was 
demonstrated to be upregulated when Vero E6 cells were infected with SARS-CoV 
(Leong et al). Based on our microarray analysis, we were able to show the same 
upregulation of the receptor gene IL8RB. 
 The protein encoded by the gene, Homo sapiens retinoblastoma-like 1 (p107) 
(RBL1), transcript variant 1, is similar in sequence and possibly function to the product 
of the retinoblastoma 1 (RB1) gene. The RB1 gene product is a tumor suppressor protein 
that appears to be involved in cell cycle regulation, as it is phosphorylated in the S to M 
phase transition and is dephosphorylated in the G1 phase of the cell cycle. Both the RB1 
protein and the product of this gene can form a complex with adenovirus E1A protein and 
SV40 large T-antigen, with the SV40 large T-antigen binding only to the 
unphosphorylated form of each protein. In addition, both proteins can inhibit the 
transcription of cell cycle genes containing E2F binding sites in their promoters. Due to 
the sequence and biochemical similarities with the RB1 protein, it is thought that the 
protein encoded by this gene may also be a tumor suppressor. Two transcript variants 
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encoding different isoforms have been found for this gene. Transcript Variant: This 
variant (1) represents the longer transcript and encodes the longer isoform (a) 
(www.ncbi.nlm.nih.gov). 
 In this study, we have used the transfection of SARS Spike construct to mimic 
actual SARS CoV infection. This is the first study that demonstrates expression of the 
Spike protein in a human cell line HL-CZ. Based on our microarray data analyses, we 
were able to observe the interplay of the transcriptomics in the cells. The varied changes 
in levels of gene regulation of the host cells in response to the transfection of the Spike 
construct yields a more streamlined insight to the “effects” of the Spike when expressed 
only. Although detection methods using real time RT-PCR and microarray yielded some 
interesting results and some conflicting reports, such methods proved useful in 
quantifying as well as identifying potential novel interacting proteins of the SARS-CoV S 
protein. A further study would then have to be conducted to investigate the data more 
extensively in the future with a more in-depth analysis of all the genes, such as using 
knock out animal models, highlighted in this report to determine their specific role and 
function in viral infections of mammals. 
 
7.0 FURTHER DIRECTIONS 
 
Although this study have not been able to yield any potential interacting partners 
for the protein 3A due to a problem with the supplier, studies have shown that the 3A is 
tissue selective and that only cells that were prior infected with the SARS-CoV were able 
to uptake the construct and express 3A (Yu et al., 2003), other studies by Tan and 
colleagues have successfully demonstrated that expression of 3A was independent of 
prior infection by the virus. More studies would have to be carried out to determine the 
expression capability of protein 3A. Its role as a minor structural protein in association 
115 
with other pivotal viral genes eg, N, M, E and S suggests that protein 3A could be a key 
target for potential therapeutics designs. However, the true function of 3A is still 
unknown. An important direction would be to establish the co-immunoprecipitation of 
protein 3A with the Spike protein to understand its role in the virulence of SARS-
CoV.The Spike protein has been a target of many study groups as it has been postulated 
to be the main virulence factor of SARS-CoV. Together with a previous colleague, our 
laboratory has been able to establish the high throughput to study gene regulation in viral 
infected and mock infected mammalian cells with the SARS-CoV using DNA 
Microarray. Future projects could explore the use of animal models knock outs to study 

















































Fig 14a. Proposed schematic diagram depicting the possible pathways downstream following transfection of HLCZ cells 





APPENDIX 1.  GROWTH MEDIA FOR TISSUE  
CULTURE OF CELL LINES 
 
 
1.1 DULBECCO MODIFIED EAGLE’S MINIMUM ESSENTIAL MEDIA  
(DMEM) 
 
 Dulbeco’s modified Eagle’s medium     1 packet 
 (Gibco-BRL, USA) 
 HEPES           47.66g 
 NaHCO3                    20g 
 
1.2 RPMI MEDIUM 1640 with 10% FCS 
 
RPMI medium 1640 with HEPES  
modification (Sigma Aldrich, USA)         1 bottle 
Fetal Calf Serum               10% v/v 
NaHCO3                  4 g     
 
One bottle of RPMI with HEPES was dissolved in 1L of sterile ddH2O followed 
by the addition of NaHCO3 and the pH adjusted to 7.2. The medium was sterilized 
by double filtration through a 0.22µm membrane.  
 
1.3 R10 FREEZING MEDIUM (COLD) 
 
RPMI medium 1650 with 10% FCS     90%  
Dimethyl sulfoxide (DMSO)      10%v/v 
 
1.4 PHOSPHATE-BUFFERED SALINE (PBS): 10X STOCK SOLUTION 
 
KCl         20g 
KH2PO4        20g 
Na2HPO4        115g 
NaCl         800g 
 
NaCl was dissolved prior to addition of the other components. The final solution 
was topped up to 10L and stirred to aid in dissolving. This stock solution was then 
filtered through 0.22µm membrane filter and autoclaved. To achieve 1X PBS, 












APPENDIX 2:  REAGENTS AND SOLUTIONS FOR  
WORKING WITH PROTEINS 
 
2.1 COLD LYSIS BUFFER FOR EUKARYOTIC CELL LINES 
 
1X PBS, pH 7.5       98.9ml 
Triton X-100          0.1ml  
Protease inhibitor (1X)           1ml  
1 tablet of protease inhibitor cocktail was dissolved in 1ml ddH2O. The 
appropriate volume from stock was added to the final lysis buffer to achieve 1X.  
 
2.2 SODIUM DODECYLE SULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) 
 
2.2.1 10% POLYACRLAMIDE SEPARATING GEL(5ML) 
ddH2O                2ml 
30% Acrylamide (Biorad)          1.7ml 
1.5M Tris, pH 8.8           1.3ml 
10% SDS          0.05ml 
10% APS          0.05ml 
TEMED        0.002ml 
 
2.2.2 STACKING GEL (5ML) 
ddH2O           1.4ml 
30% Acrylamide (Biorad)      0.33ml 
1M Tris, pH 6.8       0.25ml 
10% SDS        0.02ml 
10% APS         0.02ml 
TEMED        0.002ml 
 
2.2.3 SAMPLE LOADING BUFFER 
1m Tris, pH 6.8          625µl 
10% SDS              2ml 
2-mercaptoethanol          0.5ml 
Glycerol              1ml 
Bromophenol Blue       0.0025g 
ddH2O        topped up to 10ml 
 
2.2.4 10X LAEMMLI RUNNING BUFFER 
Tris          30.3g 
Glycine        144.2g 
SDS              10g 
ddH2O        topped up to 10ml 
 
For each SDS-PAGE electrophoresis run, the running buffer was diluted to 1X 





2.3 IMMUNOBLOTTING (WESTERN BLOT) 
2.3.1 10X CAPS, pH 11.0 
3-[cyclohexylamino]-1-propanesulfonic acid (CAPS)    22.1g 
ddH2O          950ml 
 
5N NaOH was used dropwise to adjust the final solution to pH 11.0 and topped up 
with ddH2O to a final volume of 1000ml. 
 
2.3.2 CAPS TRANSFER BUFFER 
10X CAPS          200ml 
Methanol          200ml 
ddH2O         1600ml 
 
2.3.3 COOMASSIE BRILLIANT BLUE STAINING SOLUTION 
Coomassie Brilliant Blue R-250 (Sigma)    2.5g 
Methanol        500ml 
Acetic acid        100ml 
ddH2O             topped up to 1000ml 
 
2.3.4 DESTAIN SOLUTION A 
Methanol        50ml 
Glacial Acetic Acid       7.5ml 
ddH2O         42.5ml 
 
2.3.5 DESTAIN SOLUTION B 
Methanol        90ml 
Glacial Acetic Acid       5ml 
ddH2O         5ml 
 
2.3.6 BLOCKING SOLUTION 
NaCl         4.383g 
Bovine Serum Albumin      15g 
Gelatin        1.25g 
1M Tris HCl, pH 7.5       7.5ml 
ddH2O         500ml 
 
2.3.7 TBST WASH SOLUTION (TRIS-BUFFERED SALINE & TWEENS 20)  
pH 7.4 
NaCl         4.383g 
1M Tris HCl, pH 7.5       7.5ml 
Tweens 20        0.25ml 
ddH2O           topped up to 500ml 
 
2.3.8 ALKALINE PHOSPHATASE BUFFER, pH 9.5 
NaCl         2.922g 
MgCl2         0.508g 
1M Tris HCl, pH 7.5       50ml 
ddH2O         450ml 
The solution was adjusted to pH 9.5 with 1N NaOH and topped up with ddH2O to 
a final volume of 500ml. 
120 
 
2.3.9 NITROBLUE TETRAZOLIUM (NBT) 
NBT (Sigma)        0.5g 
70% Dimethylformamide (DMF)     10ml 
 
2.4.0 BROMOCHLOROINDOYL PHOSPHATE (BCIP)    
BCIP (Sigma)        0.5g 
100% Dimethylformamide (DMF)     10ml  
 
 
2.4.1 LURIA-BERTANI (LB) BROTH (pH 7), per litre 
Bacto-tryptone (Oxoid)      10g  
Bacto-yeast extract       5g 












































3.1 Diethylpyrocarbonate (DEPC) Treated ddH2O 
To make 1 L of DEPC treated (RNase-free) water, 1ml of DEPC (Sigma) was 
added to 1 L of ddH2O. The treated water was incubated overnight at room 
temperature with stirring. The water was then autoclaved at 121oC for 15 minutes. 
 
3.1.1 75% Ethanol for washing of RNA pellet 
Absolute Ethanol       7.5ml 
DEPC-treated water       top up to 10ml 
 
3.1.2 10X Formaldehyde-Agarose (FA) Gel Buffer 
3-[N-morpholino]propanesulfonic acid (MOPS) (free acid)  200mM 
Sodium acetate       50mM 
EDTA         10mM 




3.1.3 1X Formaldehyde-Agarose (FA) Gel Running Buffer 
10X FA gel buffer       100ml 
37% (12.3 M) formaldehyde      20ml 



















APPENDIX 4 : REAGENTS FOR MICROARRAY 
EXPERIMENTS 
4.1 2 X Saline Sodium Citrate (SSC)/0.5% SDS (Hybridization Wash I) 
20X SSC     40ml 
10% SDS     20ml 
Deionised H2O    340ml 
 
4.2 0.1X Saline Sodium Citrate (SSC0/0.5% SDS (Hybridization Wash II) 
20X SSC     2ml 
10% SDS     20ml 
Deionised H2O    378ml 
 
4.3 1X Blocking Buffer 
5X Blocking buffer    20ml 
Deionised H2O    80ml 
Stored at 4OC until use 
 
4.4 1X Wash Buffer 
10X Blocking buffer    20ml 
Deionised H2O    180ml 
 
4.5 1X Detection Buffer 
10X Detection buffer    10ml 
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